<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genome Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Genome Med</journal-id>
<journal-title-group>
<journal-title>Genome Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">1756-994X</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31694722</article-id>
<article-id pub-id-type="pmc">6836550</article-id>
<article-id pub-id-type="publisher-id">675</article-id>
<article-id pub-id-type="doi">10.1186/s13073-019-0675-1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0806-5602</contrib-id>
<name>
<surname>Lindstrand</surname>
<given-names>Anna</given-names>
</name>
<address>
<email>anna.lindstrand@ki.se</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eisfeldt</surname>
<given-names>Jesper</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pettersson</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carvalho</surname>
<given-names>Claudia M. B.</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kvarnung</surname>
<given-names>Malin</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grigelioniene</surname>
<given-names>Giedre</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anderlid</surname>
<given-names>Britt-Marie</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bjerin</surname>
<given-names>Olof</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gustavsson</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hammarsjö</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Georgii-Hemming</surname>
<given-names>Patrik</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iwarsson</surname>
<given-names>Erik</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Johansson-Soller</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lagerstedt-Robinson</surname>
<given-names>Kristina</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lieden</surname>
<given-names>Agne</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Magnusson</surname>
<given-names>Måns</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martin</surname>
<given-names>Marcel</given-names>
</name>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Malmgren</surname>
<given-names>Helena</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nordenskjöld</surname>
<given-names>Magnus</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Norling</surname>
<given-names>Ameli</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sahlin</surname>
<given-names>Ellika</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stranneheim</surname>
<given-names>Henrik</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tham</surname>
<given-names>Emma</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wincent</surname>
<given-names>Josephine</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ygberg</surname>
<given-names>Sofia</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wedell</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wirta</surname>
<given-names>Valtteri</given-names>
</name>
<xref ref-type="aff" rid="Aff9">9</xref>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nordgren</surname>
<given-names>Ann</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Lundin</surname>
<given-names>Johanna</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Nilsson</surname>
<given-names>Daniel</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9241 5705</institution-id><institution-id institution-id-type="GRID">grid.24381.3c</institution-id><institution>Department of Clinical Genetics, </institution><institution>Karolinska University Hospital, </institution></institution-wrap>Stockholm, Sweden </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution>Department of Molecular Medicine and Surgery, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution>Center for Molecular Medicine, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution>Science for Life Laboratory, Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2160 926X</institution-id><institution-id institution-id-type="GRID">grid.39382.33</institution-id><institution>Department of Molecular and Human Genetics, </institution><institution>Baylor College of Medicine, </institution></institution-wrap>Houston, Texas USA </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution>The Department of Women’s and Children’s Health, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9241 5705</institution-id><institution-id institution-id-type="GRID">grid.24381.3c</institution-id><institution>Centre for Inherited Metabolic Diseases, </institution><institution>Karolinska University Hospital, </institution></institution-wrap>Stockholm, Sweden </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9377</institution-id><institution-id institution-id-type="GRID">grid.10548.38</institution-id><institution>Department of Biochemistry and Biophysics, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, </institution><institution>Stockholm University, </institution></institution-wrap>Stockholm, Sweden </aff>
<aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121581746</institution-id><institution-id institution-id-type="GRID">grid.5037.1</institution-id><institution>Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, </institution><institution>KTH Royal Institute of Technology, </institution></institution-wrap>Stockholm, Sweden </aff>
<aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution>Science for Life Laboratory, Department of Microbiology, Tumor and Cell biology, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>7</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>7</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>11</volume>
<elocation-id>68</elocation-id>
<history>
<date date-type="received">
<day>7</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>9</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Since different types of genetic variants, from single nucleotide variants (SNVs) to large chromosomal rearrangements, underlie intellectual disability, we evaluated the use of whole-genome sequencing (WGS) rather than chromosomal microarray analysis (CMA) as a first-line genetic diagnostic test.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">We analyzed three cohorts with short-read WGS: (i) a retrospective cohort with validated copy number variants (CNVs) (cohort 1, <italic>n</italic> = 68), (ii) individuals referred for monogenic multi-gene panels (cohort 2, <italic>n</italic> = 156), and (iii) 100 prospective, consecutive cases referred to our center for CMA (cohort 3). Bioinformatic tools developed include FindSV, SVDB, Rhocall, Rhoviz, and vcf2cytosure.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">First, we validated our structural variant (SV)-calling pipeline on cohort 1, consisting of three trisomies and 79 deletions and duplications with a median size of 850 kb (min 500 bp, max 155 Mb). All variants were detected. Second, we utilized the same pipeline in cohort 2 and analyzed with monogenic WGS panels, increasing the diagnostic yield to 8%. Next, cohort 3 was analyzed by both CMA and WGS. The WGS data was processed for large (&gt; 10 kb) SVs genome-wide and for exonic SVs and SNVs in a panel of 887 genes linked to intellectual disability as well as genes matched to patient-specific Human Phenotype Ontology (HPO) phenotypes. This yielded a total of 25 pathogenic variants (SNVs or SVs), of which 12 were detected by CMA as well. We also applied short tandem repeat (STR) expansion detection and discovered one pathologic expansion in <italic>ATXN7</italic>. Finally, a case of Prader-Willi syndrome with uniparental disomy (UPD) was validated in the WGS data.</p>
<p id="Par4">Important positional information was obtained in all cohorts. Remarkably, 7% of the analyzed cases harbored complex structural variants, as exemplified by a ring chromosome and two duplications found to be an insertional translocation and part of a cryptic unbalanced translocation, respectively.</p>
</sec>
<sec>
<title>Conclusion</title>
<p id="Par5">The overall diagnostic rate of 27% was more than doubled compared to clinical microarray (12%). Using WGS, we detected a wide range of SVs with high accuracy. Since the WGS data also allowed for analysis of SNVs, UPD, and STRs, it represents a powerful comprehensive genetic test in a clinical diagnostic laboratory setting.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Whole-genome sequencing</kwd>
<kwd>Intellectual disability</kwd>
<kwd>Monogenic disease</kwd>
<kwd>Copy number variation</kwd>
<kwd>Structural variation</kwd>
<kwd>Single nucleotide variant</kwd>
<kwd>Uniparental disomy</kwd>
<kwd>Repeat expansion</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>Science for Life Laboratory</institution>
</funding-source>
<award-id>National sequencing grant</award-id>
<principal-award-recipient>
<name>
<surname>Lindstrand</surname>
<given-names>Anna</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Stockholm County Council</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id>
<institution>Vetenskapsrådet</institution>
</institution-wrap>
</funding-source>
<award-id>2018-02652</award-id>
<award-id>2017-02936</award-id>
<principal-award-recipient>
<name>
<surname>Lindstrand</surname>
<given-names>Anna</given-names>
</name>
<name>
<surname>Nordgren</surname>
<given-names>Ann</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003792</institution-id>
<institution>Hjärnfonden</institution>
</institution-wrap>
</funding-source>
<award-id>None</award-id>
<award-id>None</award-id>
<principal-award-recipient>
<name>
<surname>Lindstrand</surname>
<given-names>Anna</given-names>
</name>
<name>
<surname>Nordgren</surname>
<given-names>Ann</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Karolinska Institutet</institution>
</funding-source>
<award-id>KID</award-id>
<principal-award-recipient>
<name>
<surname>Pettersson</surname>
<given-names>Maria</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Knut and Alice Wallenberg Foundation</institution>
</funding-source>
<award-id>National Bioinformatics Infrastructure Sweden, SciLifeLab</award-id>
<principal-award-recipient>
<name>
<surname>Martin</surname>
<given-names>Marcel</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006516</institution-id>
<institution>Bertil Hållstens Forskningsstiftelse</institution>
</institution-wrap>
</funding-source>
<award-id>None</award-id>
<principal-award-recipient>
<name>
<surname>Nordgren</surname>
<given-names>Ann</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005753</institution-id>
<institution>Kungliga Fysiografiska Sällskapet i Lund</institution>
</institution-wrap>
</funding-source>
<award-id>Nilsson-Ehle donationerna</award-id>
<principal-award-recipient>
<name>
<surname>Pettersson</surname>
<given-names>Maria</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par33">Up to 80% of rare diseases have a genetic background [<xref ref-type="bibr" rid="CR1">1</xref>], and in the last decade, our understanding of the underlying genetic lesions has increased rapidly. Since human genetic variation is abundant and diverse, ranging from small variants affecting only one or a few base pairs, i.e., single nucleotide variants (SNVs), small insertions and deletions (INDELs) to large structural variants (SVs) affecting thousands or millions of nucleotides [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR4">4</xref>], diagnostic tests need to capture the full spectrum of variation. Technological advancements in high-throughput sequencing (massively parallel sequencing, MPS) has allowed for comprehensive sequencing of many individuals from various populations [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR7">7</xref>] highlighting the vast complexity and abundance of rare and common genetic variation [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>].</p>
<p id="Par34">In genetic diagnostics, the current toolbox includes a great variety of cytogenetic and molecular methodologies. Chromosomal microarray analysis (CMA), either comparative genomic hybridization (CGH) or SNP arrays, has long been the first-tier test used to identify copy number variants (CNVs) in individuals with intellectual disability and neurodevelopmental disorders [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>]. In recent years, MPS-based assays have been increasingly used in rare disease diagnostics, because of their high throughput and cost effectiveness in screening multi-gene panels for hereditary disorders [<xref ref-type="bibr" rid="CR13">13</xref>]. Whole-exome sequencing (WES) is more and more widely used in clinical labs as a first-tier test, allowing detection of SNVs, INDELs, and CNVs covering multiple exons (typically &gt; 2) [<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref>]. In a recent meta-analysis, the diagnostic yield of WES in 3350 individuals with neurodevelopmental disorders was 36%, ranging from 8 to 90%, with the higher yield obtained after trio analysis of the affected individuals and both parents [<xref ref-type="bibr" rid="CR17">17</xref>]. Even though isolated WES or WES in combination with CMA enables effective detection of both SNVs and CNVs [<xref ref-type="bibr" rid="CR18">18</xref>], some types of variants such as balanced chromosomal rearrangements, small CNVs (&lt; 2 exons), and trinucleotide repeat expansion disorders will be missed. Depending on the specific clinical presentation and the preferences of the referring physician and the laboratory performing the test, other assays such as G-banded karyotyping, fluorescence <italic>in situ</italic> hybridization (FISH), <italic>FMR1</italic> CGG repeat expansion analysis, PCR-based single gene analysis, and whole-genome sequencing (WGS) may then be performed [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
<p id="Par35">Each individual method has intrinsic specific limitations which may result in causal variants being missed (e.g., mosaicism in probands) or misinterpreted (e.g., gene copy number gains consistent with triplications or higher order gains can be challenging to distinguish from duplications [<xref ref-type="bibr" rid="CR20">20</xref>]), resulting in sub-optimal clinical management and imprecise genetic counseling [<xref ref-type="bibr" rid="CR21">21</xref>]. In addition, the possibility of dual diagnosis due to multi-locus variation [<xref ref-type="bibr" rid="CR22">22</xref>] has been reported for up to 5% of individuals with Mendelian diseases and can explain apparent phenotypic expansion [<xref ref-type="bibr" rid="CR23">23</xref>]. In research, WGS has been used to detect a wide range of mutations, including copy number variations [<xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR26">26</xref>] as well as balanced chromosomal rearrangements such as translocations [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>], inversions [<xref ref-type="bibr" rid="CR29">29</xref>], and short tandem repeats (STRs) [<xref ref-type="bibr" rid="CR30">30</xref>]. A few studies have performed CNV calling from WGS in small cohorts, showing diagnostic rates of 15% (10/79) [<xref ref-type="bibr" rid="CR24">24</xref>], 33% (20/60) [<xref ref-type="bibr" rid="CR31">31</xref>], and 14% (7/50) [<xref ref-type="bibr" rid="CR32">32</xref>]. Although WGS is the most comprehensive test currently available for molecular diagnostics in clinical practice, the routine use of WGS largely remains limited to SNVs and INDELs [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. This is because WGS-based SV detection in a clinical setting remains challenging, partly because of the low precision and sensitivity of the SV callers and lack of normal variant databases, but also due to the limited standardization and benchmarking of the various pipelines [<xref ref-type="bibr" rid="CR35">35</xref>].</p>
<p id="Par36">In this study, we investigate the application of WGS as a first-line test in intellectual disability and compare the outcome with results from CMA. In aggregate, the results highlight the ability to capture a broad range of genetic variation including both large and small CNVs, SNVs, balanced rearrangements, repeat expansions, and uniparental disomy (UPD). In a prospective unselected cohort of 100 patients referred to our laboratory for CMA, the overall diagnostic yield of WGS was 27% compared to 12% obtained with our standard clinical CMA.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Study subjects</title>
<p id="Par37">Clinical Genetics (Karolinska University Hospital, Stockholm, Sweden) is a tertiary center where genome-wide screening for CNVs by CMA is used as a first-line test for individuals with suspected rare genetic disease, neurodevelopmental disorders (NDD), and malformation syndromes. For individuals with a high suspicion of a monogenic disease, WGS (with <italic>in silico</italic> gene panel analysis) is performed as the first-line test. Overall, roughly 1000 CMAs and 500 WGS analyses are performed annually. In this study, all included patients were initially referred for clinical diagnostic testing and, when possible, parental analysis was performed to assess the parental origin of identified variants. Three cohorts were investigated:
<list list-type="bullet"><list-item><p id="Par38">Cohort 1, “The validation cohort”, consisted of 68 individuals harboring three trisomies and 79 CNVs previously detected by CMA or multiplex ligation-dependent probe amplification (MLPA).</p></list-item><list-item><p id="Par39">Cohort 2, “The monogenic disease study cohort”, consisted of 156 individuals referred for WGS due to a clinical suspicion of monogenic disease within the areas of neuromuscular disorders, connective tissue disorders, unknown syndromes, skeletal dysplasias, hereditary cancer, or other rare suspected Mendelian conditions.</p></list-item><list-item><p id="Par40">Cohort 3, “The prospective study cohort”, consisted of the first 100 unselected individuals that were clinically referred for CMA in 2017.</p></list-item></list></p>
<p id="Par41">The clinical parameters of the three cohorts are summarized in Table <xref ref-type="table" rid="Tab1">1</xref> and detailed information is given in Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1. The local ethical board in Stockholm, Sweden, approved the study (approval numbers KS 2012/222-31/3 and 2012/2106-31/4).
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Clinical parameters of included cases</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Clinical</th><th>Cohort 1 (<italic>n</italic> = 68)</th><th>Cohort 2 (<italic>n</italic> = 156)</th><th>Cohort 3 (<italic>n</italic> = 100)</th></tr></thead><tbody><tr><td>Gender (F/M)</td><td>44%/56%</td><td>44%/50%*</td><td>37%/63%</td></tr><tr><td colspan="4">Main phenotype</td></tr><tr><td> NDD</td><td>21 (31%)</td><td>2 (1%)</td><td>40 (40%)</td></tr><tr><td> NDD+</td><td>13 (19%)</td><td>0</td><td>38 (38%)</td></tr><tr><td> Syndrome</td><td>20 (29%)</td><td>53 (34%)</td><td>8 (8%)</td></tr><tr><td> Growth abnormality</td><td>5 (7%)</td><td>0</td><td>4 (4%)</td></tr><tr><td> Metabolic crisis</td><td>0</td><td>0</td><td>3 (3%)</td></tr><tr><td> Endocrine abnormality</td><td>2 (3%)</td><td>0</td><td>1 (1%)</td></tr><tr><td> Internal malformations</td><td>1 (1%)</td><td>0</td><td>2 (2%)</td></tr><tr><td> Neuromuscular abnormality</td><td>1 (1%)</td><td>32 (21%)</td><td>2 (2%)</td></tr><tr><td> CTD</td><td>0</td><td>28 (18%)</td><td>0</td></tr><tr><td> Hereditary cancer</td><td>3 (4%)</td><td>33 (21%)</td><td>0</td></tr><tr><td> Other**</td><td>2 (3%)</td><td>8 (5%)</td><td>2 (2%)</td></tr></tbody></table><table-wrap-foot><p><italic>F</italic> female, <italic>M</italic> male, <italic>NDD</italic> neurodevelopmental disorder, <italic>NDD+</italic> syndromic NDD, <italic>CTD</italic> connective tissue disorder. *6% no gender information (fetal sample or disorder of sex development). **Epilepsy, disorder of sex development, eye disorder, immunological disorder, and skin disease</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec4">
<title>Chromosomal microarray analysis</title>
<p id="Par42">Genomic DNA was isolated from whole blood using standardized protocols and used for array comparative genomic hybridization (array-CGH) analysis. A 4 × 180K custom oligonucleotide microarray with whole-genome coverage and a median probe spacing of approximately 18 kb was used (AMADID:031035, Oxford Gene Technology, Begbroke, Oxfordshire, UK). This array design is used as a routine diagnostic tool at the Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. For sample RD_P409, a medical exome 1 × 1 M Agilent oligonucleotide microarray was used (AMADID:068073, Oxford Gene Technology, Begbroke, Oxfordshire, UK). The medical exome 1 × 1 M array is an exon-focused array used for targeted analysis of deletions/duplications falling below the resolution of the 4 × 180K standard microarray. The probes have been selected to allow for single exon resolution in 4645 known disease-causing genes.</p>
<p id="Par43">The control DNA used for the array-CGH experiment consisted of a mix of sex-matched DNA from several healthy individuals pooled together (Promega, Madison, WI, USA). Sample labelling (CGH labelling kit for oligo arrays, Enzo Life Sciences, Farmingdale, NY, USA), hybridization, and slide washing (Oligo aCGH/ChIP-on-Chip Wash Buffer Kit, Agilent Technologies, Wilmington, DE, USA) were performed according to the manufacturers’ recommendations. Slides were scanned using the Agilent Microarray Scanner (G2505C, Agilent technologies, USA) with 3 μm resolution. Raw data were normalized using Feature Extraction Software v10.7.3.1 (Agilent Technologies, Santa Clara, CA, USA), and log2 ratios were calculated by dividing the normalized intensity in the sample by the mean intensity across the reference sample. The log2 ratios were plotted and segmented by circular binary segmentation in the CytoSure Interpret software v4.10 (Oxford Gene Technology, Oxfordshire, UK). Oligonucleotide probe positions were annotated according to the human genome assembly hg19 [<xref ref-type="bibr" rid="CR36">36</xref>]. For the 4×180K microarray, three consecutive aberrant probes with a log2 ratio cutoff of − 0.65 for deletions and 0.35 for duplications were called, giving a practical lower resolution of about 50 kb. The clinical relevance of all CNVs was classified into five categories; benign, likely benign, variant of uncertain significance (VUS), likely pathogenic, and pathogenic, according to the American College of Medical Genetics and Genomics (ACMG) guidelines [<xref ref-type="bibr" rid="CR37">37</xref>] and based upon the size of aberration, gene content, inheritance, and available information in medical literature and different databases: the Database of Genomic Variants (DGV) [<xref ref-type="bibr" rid="CR38">38</xref>], the Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources (DECIPHER) [<xref ref-type="bibr" rid="CR39">39</xref>], Online Mendelian Inheritance in Man (OMIM) [<xref ref-type="bibr" rid="CR40">40</xref>], and an in-house database with variants from ~ 8000 analyzed cases.</p>
</sec>
<sec id="Sec5">
<title>Multiplex ligation-dependent probe amplification</title>
<p id="Par44">Multiplex ligation-dependent probe amplification (MLPA) analysis was performed using the available probe set for selected assays (P090 (<italic>BRCA2</italic>), P256 (<italic>FLCN</italic>), P003 (<italic>MLH1</italic>), and ME028 (PWS) MRC-Holland, Amsterdam, Netherlands). MLPA was carried out according to the supplier’s recommendations, with the exception that the PCR reactions were performed in a 25-μl reaction volume. Amplification products were quantified by capillary electrophoresis on an ABI3500xL Genetic Analyzer (Applied Biosystems, Thermo Fisher Scientific, Waltham, MA, USA) with accompanying software. The tracing data was imported into and analyzed in GeneMarker software v1.7 (SoftGenetics LLC, State College, PA, USA). The normalized quotients for the different probes were considered as a deletion when below 0.75 and a duplication when above 1.3.</p>
</sec>
<sec id="Sec6">
<title>Genotyping</title>
<p id="Par45">Genomic DNA from individual RD_P432 and her mother were analyzed using 12 polymorphic microsatellite markers located on chromosome 15 (D15S1035, D15S128, D15S1513, D15S97, D15S1002, D15S165, D15S1007, D15S123, D15S1024, D15S992, D15S1028, and D15S978). Primers were pooled and amplified using Type-it Microsatellite PCR Kit according to the manufacturer’s instructions (QIAGEN, Hilden, Germany). PCR products were analyzed using 3500xL Genetic Analyzer and GeneMapper v5 according to the manufacturer’s protocol (Applied Biosystems).</p>
</sec>
<sec id="Sec7">
<title>Short-read whole-genome sequencing</title>
<p id="Par46">Genomic DNA from whole blood was sequenced using the Illumina Hiseq X Ten platform, using a 30× PCR-free paired-end WGS protocol. The patients of cohort 1 (<italic>n</italic> = 68) were sequenced at the National Genomics Infrastructure (NGI), Stockholm, Sweden [<xref ref-type="bibr" rid="CR41">41</xref>], and the patients of cohort 2 (<italic>n</italic> = 156) and cohort 3 (<italic>n</italic> = 100) were sequenced at Clinical Genomics, Stockholm, Sweden [<xref ref-type="bibr" rid="CR42">42</xref>]. The resulting WGS data was preprocessed according to the GATK best practices for germline WGS data [<xref ref-type="bibr" rid="CR43">43</xref>]. SVs were analyzed using the FindSV pipeline [<xref ref-type="bibr" rid="CR44">44</xref>], a pipeline combining CNVnator V0.3.2 [<xref ref-type="bibr" rid="CR45">45</xref>] and TIDDIT V2.0.0 [<xref ref-type="bibr" rid="CR46">46</xref>]. The outputs of these callers (~ 27,000 SVs; Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S1) are merged using SVDB [<xref ref-type="bibr" rid="CR47">47</xref>], and the resulting variant calling file (VCF) is annotated using variant effect predictor (VEP) 87 [<xref ref-type="bibr" rid="CR48">48</xref>]. Finally, the VCF is annotated and sorted based on the allele frequencies in the Swedish structural variant frequency database (SweFreq SVDB) [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR49">49</xref>], as well as an internal database (internal SVDB) consisting of approximately 400 individuals.</p>
<p id="Par47">SNVs were called using MIP [<xref ref-type="bibr" rid="CR34">34</xref>], a pipeline that combines Samtools [<xref ref-type="bibr" rid="CR50">50</xref>], FreeBayes [<xref ref-type="bibr" rid="CR51">51</xref>], and the GATK HaplotypeCaller [<xref ref-type="bibr" rid="CR43">43</xref>] generating an average of 5,500,000 SNVs and INDELS (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S2). Finally, ExpansionHunter v2.5.5 [<xref ref-type="bibr" rid="CR30">30</xref>] was applied to the Illumina short-read whole-genome alignment files produced by MIP v.6.0.0, assessing STRs in 17 genes (<italic>AR</italic>, <italic>ATN1</italic>, <italic>ATXN1</italic>, <italic>ATXN10</italic>, <italic>ATXN2</italic>, <italic>ATXN3</italic>, <italic>ATXN7</italic>, <italic>C9ORF72</italic>, <italic>CACNA1A</italic>, <italic>CBL</italic>, <italic>CSTB</italic>, <italic>DMPK</italic>, <italic>FMR1</italic>, <italic>FXN</italic>, <italic>HTT</italic>, <italic>JPH3</italic>, and <italic>PPP2R2B</italic>).</p>
</sec>
<sec id="Sec8">
<title>Data analysis of WGS data in the prospective study</title>
<p id="Par48">The WGS data was analyzed in three steps: (1) large CNVs, (2) small CNVs and genomic rearrangements, and (3) SNVs, INDELS, and repeat expansions. A panel of genes linked to intellectual disability (ID gene panel) that consisted of 887 genes was generated based on the information available at the time through the Genomics England panel app [<xref ref-type="bibr" rid="CR52">52</xref>] (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Document S1) which was used for filtering small CNVs, SNVs, and INDELS. In addition, for individuals with other clinical symptoms, personalized gene panels were generated based on the patient-specific Human Phenotype Ontology (HPO) [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>] terms using the database available through Charité [<xref ref-type="bibr" rid="CR55">55</xref>] to link the HPO terms and genes.</p>
<p id="Par49">For SV analysis (aforementioned steps 1 and 2), the output data from FindSV was filtered based on variant size (intergenic variants &gt; 10 kb, and intragenic variants &gt; 2 kb), quality (minimum 6 read pairs (TIDDIT), minimum 5 kb in size (CNVnator)), and allele frequency (SweFreq SVDB &lt; 0.5%, internal SVDB &lt; 1%), and calls located on the decoy contig were also filtered out. Finally, a list of SVs with junctions located within the ID or HPO gene list was generated without a size cutoff. The number of SVs remaining after each filtering step is available in the supplemental data (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S1).
<list list-type="bullet"><list-item><p id="Par50">Step 1: To visualize large CNVs, we used vcf2cytosure [<xref ref-type="bibr" rid="CR56">56</xref>] that converts a VCF with structural variations to the “.CGH” format used by the CytoSure Interpret Software by OGT. CytoSure is normally used in our laboratory to interpret the clinical significance of CNVs detected by CMA. By displaying the WGS data in a familiar system where we have access to a large internal database of previously assessed cases, variant classification is facilitated (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S3). As described in the CMA section, detected CNVs were classified into five categories according to the ACMG guidelines [<xref ref-type="bibr" rid="CR57">57</xref>].</p></list-item><list-item><p id="Par51">Step 2: Selected SVs were visualized in a list view enabling more detailed assessment of balanced/complex genomic rearrangements. Indications of a genomic rearrangement include (i) several SVs in the same genomic region, (ii) discordant read pairs mapping from a duplication/deletion boundary to another chromosomal region, and (iii) several CNVs clustering on the same chromosome. All such variants of interest were then inspected in IGV, and the derivative chromosomes were reconstructed by visual inspection and breakpoint junction analysis [<xref ref-type="bibr" rid="CR58">58</xref>].</p></list-item><list-item><p id="Par52">Step 3: SNVs and INDELS were annotated using MIP [<xref ref-type="bibr" rid="CR34">34</xref>] and repeat expansions with ExpansionHunter [<xref ref-type="bibr" rid="CR30">30</xref>]. Rare variants with a minor allele frequency (MAF) less than 1% in Exome Aggregation Consortium (ExAC) [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR59">59</xref>] or in the Swedish variant frequency database (SweFreq) [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR60">60</xref>] and located within the ID or HPO gene list were considered for further analysis. We then used an internal scoring system that also takes into account conservation and predicted severity of the variant [<xref ref-type="bibr" rid="CR34">34</xref>] that is available on GitHub [<xref ref-type="bibr" rid="CR61">61</xref>]. The number of SNVs remaining after each filtering step is available in the supplemental data (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S2). Finally, remaining variants were individually assessed and classified according to ACMG guidelines [<xref ref-type="bibr" rid="CR57">57</xref>] into five classes; benign, likely benign, likely pathogenic, pathogenic, and uncertain significance.</p></list-item></list></p>
<p id="Par53">All SNVs and CNVs reported in this study have been submitted to the ClinVar database [<xref ref-type="bibr" rid="CR62">62</xref>].</p>
<p id="Par54">Finally, in individual RD_P432, maternal uniparental disomy (UPD) for chromosome 15 was assessed in the WGS data. In brief, this was done in two steps using in-house developed bioinformatic tools. First, we searched for regions of homozygosity on chromosome 15 using rhocall [<xref ref-type="bibr" rid="CR63">63</xref>] and then we made a run of homozygozity (RoH) plot using the rhoviz tool from the same package. In brief, this assesses zygosity ratios at all SNPs across an entire chromosome (in this case chromosome 15). The zygosity ratio is defined as the ratio of high-quality variants in a local region supporting a heterozygous allele to the total number of high-quality variants in that region.</p>
</sec>
<sec id="Sec9">
<title>Verification of variants identified by WGS</title>
<p id="Par55">SNVs were verified with PCR and Sanger sequencing. For the two deletions in <italic>MBD5</italic> and <italic>C12orf65</italic> identified by WGS in individuals RD_P416 and RD_P417, respectively, and the reciprocal translocation between chromosomes 4 and 7 (RD_P77) (Table <xref ref-type="table" rid="Tab3">3</xref>), primers flanking the breakpoints were designed approximately 500 base pairs away from the estimated breakpoints. The same primers were subsequently used for sequencing using the Sanger method (primer sequences available upon request). The PCR was performed using standard methods with Platinum Taq DNA Polymerase (Invitrogen, Carlsbad, CA, USA). Sequences were aligned using BLAT (UCSC Genome Browser) [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>] and visualized in the CodonCode Aligner software (CodonCode Corp., Dedham, MA, USA).</p>
<p id="Par56">The <italic>ATXN7</italic> STR identified in individual RD_P431 was verified and the exact number of CAG copies determined using PCR followed by fragment length analysis [<xref ref-type="bibr" rid="CR66">66</xref>]. The length of the PCR products was determined using capillary electrophoresis on an ABI3500xL Genetic Analyzer and the software Gene Mapper v5 (Applied Biosystems, Thermo Fisher Scientific, Waltham, MA, USA).</p>
<p id="Par57">Fluorescence <italic>in situ</italic> hybridization (FISH) was performed using standardized protocols from peripheral blood cultures from patient RD_P405, harboring a duplication on chromosome 3 where the WGS data suggested that the duplication had been inserted on chromosome 13. Probes used were RP11-209H21-SG (green, chr3:159,243,721-159,420,409 (Hg19)) and RP11-203L15SO (red, chr3:160,561,956-160,724,921 (Hg19)).</p>
<p id="Par58">Chromosome analysis was performed on metaphases from peripheral blood cultures from patients RD_P406 and RD_P414 according to standard protocols with subsequent G-banding with an approximate resolution of 550 bands per haploid genome. A total of 12 metaphases were analyzed.</p>
</sec>
</sec>
<sec id="Sec10">
<title>Results</title>
<sec id="Sec11">
<title>WGS reliably identifies deletions, duplications, and aneuploidies and reveals additional clinically relevant genetic information</title>
<p id="Par59">To validate the SV calling pipeline, a total of 68 individuals with three trisomies and 79 CNVs, previously detected by CMA (65 individuals) or MLPA (three individuals), including 54 deletions and 25 duplications, were subjected to short-read WGS sequencing (Fig. <xref ref-type="fig" rid="Fig1">1</xref>, Table <xref ref-type="table" rid="Tab2">2</xref>, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1) and analyzed with the FindSV pipeline that includes the two SV callers: CNVnator [<xref ref-type="bibr" rid="CR45">45</xref>] and TIDDIT [<xref ref-type="bibr" rid="CR46">46</xref>]. All validation CNVs were detected in the WGS data. The two callers performed slightly differently, mainly depending on whether the CNV breakpoints were located in repetitive regions (Table <xref ref-type="table" rid="Tab2">2</xref>). The size distribution of the variants ranged from 500 bp (single exon CNVs) to 155 Mb (whole chromosome) (Fig. <xref ref-type="fig" rid="Fig1">1</xref>, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1).
<fig id="Fig1"><label>Fig. 1</label><caption><p>Overview of CNVs and affected individuals included in the validation cohort. <bold>a</bold> Bar graph showing the size distribution of 79 validated CNVs and three trisomies that were detected with WGS. Deletions are shown in purple, duplications in black, and trisomies in lilac. <bold>b</bold> Array comparative genomic hybridization plot indicates a heterozygous deletion of 9.3 Mb in individual RD_P77. <bold>c</bold> Circos plot illustrating the WGS results in the same individual. Discordant read pairs between chromosomes 4 and 7 are shown as gray lines, and the deletion is shown in red</p></caption><graphic id="MO1" xlink:href="13073_2019_675_Fig1_HTML"></graphic></fig>
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Overview of the 80 validated CNVs detected by CMA and WGS in 68 patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Type</th><th>Found by TIDDIT</th><th>Found by CNVnator</th><th>Found by CMA</th></tr></thead><tbody><tr><td colspan="4">Deletions</td></tr><tr><td> Recurrent [<xref ref-type="bibr" rid="CR7">7</xref>]</td><td>0 (0%)</td><td>7 (100%)</td><td>7 (100%)</td></tr><tr><td> Non-recurrent [<xref ref-type="bibr" rid="CR47">47</xref>]</td><td>39 (83%)</td><td>44 (94%)</td><td>43 (91%)</td></tr><tr><td> Total [<xref ref-type="bibr" rid="CR54">54</xref>]</td><td>39 (72%)</td><td>51 (94%)</td><td>50 (93%)</td></tr><tr><td colspan="4">Duplications</td></tr><tr><td> Recurrent [<xref ref-type="bibr" rid="CR5">5</xref>]</td><td>0 (0%)</td><td>5 (100%)</td><td>5 (100%)</td></tr><tr><td> Non-recurrent [<xref ref-type="bibr" rid="CR18">18</xref>]</td><td>15 (83%)</td><td>16 (89%)</td><td>15 (83%)</td></tr><tr><td> Total [<xref ref-type="bibr" rid="CR23">23</xref>]</td><td>15 (65%)</td><td>20 (87%)</td><td>21 (91%)</td></tr><tr><td colspan="4">Trisomies</td></tr><tr><td> Total [<xref ref-type="bibr" rid="CR3">3</xref>]</td><td>3 (100%)</td><td>3 (100%)</td><td>3 (100%)</td></tr></tbody></table><table-wrap-foot><p><italic>CMA</italic> chromosomal microarray, <italic>WGS</italic> whole-genome sequencing</p></table-wrap-foot></table-wrap></p>
<sec id="Sec12">
<title>Deletions</title>
<p id="Par60">A total of 54 deletions were identified in cohort 1, including seven recurrent (13%) and 47 non-recurrent (87%) (Table <xref ref-type="table" rid="Tab2">2</xref>). The size ranged between 5 kb and 47 Mb (Fig. <xref ref-type="fig" rid="Fig1">1</xref>, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1). TIDDIT identified a total of 39 deletions (83%), all of which were non-recurrent while CNVnator identified a total of 51 deletions (94%), including all recurrent deletions (Table <xref ref-type="table" rid="Tab2">2</xref>). The seven recurrent deletions included four contiguous gene syndromes: DiGeorge syndrome (22q11.21 deletion; MIM 188400), Chromosome 1p36 deletion syndrome (MIM 607872), Chromosome 16p11.2 deletion syndrome (MIM 611913), and Prader-Willi syndrome (MIM 176270) due to a 15q11.2 deletion (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1).</p>
</sec>
<sec id="Sec13">
<title>Duplications</title>
<p id="Par61">A total of 23 unique duplications were identified in cohort 1, five of which were recurrent (22%) and 18 were non-recurrent (78%) (Table <xref ref-type="table" rid="Tab2">2</xref>). The size of the duplications ranged between 474 bp and 36.4 Mb (Fig. <xref ref-type="fig" rid="Fig1">1</xref>, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1). All five recurrent duplications were detected by CNVnator. The recurrent duplications included two contiguous gene syndromes, the 22q11.21 duplication syndrome (MIM 608363; two individuals) and the 16p11.2 duplication syndrome (MIM 614671) (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1). Two duplications were part of complex rearrangements and are discussed below. Of the 16 unique simple duplications, 13 (81%) were found by TIDDIT, allowing for determination of the positioning of the duplicated segments. It was found that all those duplications were in tandem (Table <xref ref-type="table" rid="Tab2">2</xref>, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1).</p>
</sec>
<sec id="Sec14">
<title>Trisomies</title>
<p id="Par62">Three of the individuals in cohort 1 harbored chromosomal aneuploidies, one case with a mosaic trisomy 9 (RD_P167), one with trisomy 21 (RD_P25), and one with trisomy X (RD_P101) (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1). In all cases, the trisomy was detected by CNVnator and verified with the coverage track provided by TIDDIT [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. In individual RD_P167, the mosaicism level was estimated to be ~ 46% with CMA and karyotyping showed it to be present in ~ 29% (15/51) of analyzed metaphases. The WGS data confirmed the presence of a mosaic trisomy 9 present in ~ 46% of cells.</p>
</sec>
<sec id="Sec15">
<title>Complex rearrangements</title>
<p id="Par63">Three rearrangements in the validation cohort were known to be complex from the molecular cytogenetics analysis: RD_P22 (DEL-NML-DEL), RD_P07 (DEL-NML-DEL-NML-DUP), RD_P05 (DEL-DUP-DEL) (DEL; deletion, NML; normal, DUP; duplication) (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1), and in an additional five individuals (5/68, 7%), the WGS analysis identified unexpected complexities compared to the original molecular cytogenetic results. These five unexpectedly complex cases included two DEL-INV-DEL rearrangements (RD_P54, RD_P26) and two DUP-NML-DUP rearrangements (RD_P106, RD_P105). The results from those eight cases have been reported previously in an article focused on the detailed characterization of clustered CNVs [<xref ref-type="bibr" rid="CR68">68</xref>].</p>
<p id="Par64">In addition, a 9.3-Mb <italic>de novo</italic> deletion on chromosome 4 turned out to be part of a reciprocal translocation between chromosomes 4 and 7 (RD_P77) (Fig. <xref ref-type="fig" rid="Fig1">1</xref>, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1). The reciprocal translocation was confirmed with breakpoint junction PCR that confirmed the presence of both junctions. The breakpoint junction analysis of the rearrangement (t(4;7)(q33;p21.3)) revealed non-templated insertions of 8 and 5 nucleotides in both junctions and no microhomologies, consistent with non-homologous end-joining (NHEJ), the most prevalent formation mechanism underlying reciprocal translocations [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR69">69</xref>] (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S4).</p>
</sec>
</sec>
<sec id="Sec16">
<title>Implementation of WGS-SV calling in monogenic rare diseases increases the diagnostic yield</title>
<p id="Par65">Next, we explored the diagnostic yield of gene-focused SV analysis in 156 patients referred for genetic investigation due to a clinical suspicion of monogenic disease. At the Karolinska University Hospital, we have since 2015 used WGS in individuals with a clinical suspicion of monogenic diseases to screen for SNVs and INDELs in multi-gene panels created by <italic>in silico</italic> filtering of the WGS data. Here we sought to implement SV calling focused on variants within the patient-specific <italic>in silico</italic> panel. In this way, we identified 12 clinically relevant SVs (8%): eight deletions, two duplications, one inversion, and one complex rearrangement with two deletions and an inversion (DEL-INV-DEL) (Table <xref ref-type="table" rid="Tab3">3</xref>, Fig. <xref ref-type="fig" rid="Fig2">2</xref>) increasing the diagnostic yield.
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Clinically relevant structural variants detected in 156 clinical WGS <italic>in silico</italic> gene panels</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Sample ID</th><th>Reason for referral</th><th>Aberration type</th><th>Zygosity</th><th>Gene</th><th>Coordinates (hg19)</th><th>Size (bp)</th><th>Classification</th></tr></thead><tbody><tr><td>RD_P391</td><td>SKD</td><td>Deletion</td><td>Heterozygous*</td><td><italic>DYNC2H1</italic> (exons 19–78)</td><td>chr11:103016472-103177263</td><td>161,791</td><td>Likely pathogenic</td></tr><tr><td>RD_P392</td><td>Malformations</td><td>Deletion</td><td>Homozygous</td><td><italic>B9D1</italic> (exon 4)</td><td>chr17:19250943-19251153</td><td>210</td><td>Pathogenic</td></tr><tr><td rowspan="3">RD_P393</td><td rowspan="3">Epilepsy</td><td>Deletion</td><td>Heterozygous</td><td><italic>SCN3A</italic> (exon 1<italic>)</italic>, <italic>CSRNP3</italic>, <italic>GALNT3</italic> (whole gene)</td><td>chr2:166050817-166679227</td><td>628,410</td><td rowspan="3">Pathogenic</td></tr><tr><td>Inversion</td><td>Heterozygous</td><td><italic>TTC21B</italic> (whole gene)</td><td>chr2:166679228-166818452</td><td>139,224</td></tr><tr><td>Deletion</td><td>Heterozygous</td><td><italic>SCN1A</italic> (whole gene)</td><td>chr2:166818453-166939516</td><td>121,063</td></tr><tr><td>RD_P394</td><td>NMD</td><td>Duplication</td><td>Homozygous</td><td><italic>LAMA2</italic> (exon 30)</td><td>chr6:129655050-129670080</td><td>15,030</td><td>Pathogenic</td></tr><tr><td>RD_P395</td><td>NMD</td><td>Duplication</td><td>Homozygous</td><td><italic>LAMA2</italic> (exon 30)</td><td>chr6:129655050-129670080</td><td>15,030</td><td>Pathogenic</td></tr><tr><td>RD_P396</td><td>NMD</td><td>Deletion</td><td>Heterozygous</td><td><italic>DMD</italic> (exon 45)</td><td>chrX:31973924-32017000</td><td>43,076</td><td>Pathogenic</td></tr><tr><td>RD_P397</td><td>NMD</td><td>Deletion</td><td>Hemizygous</td><td><italic>DMD</italic> (exon 3–21)</td><td>chrX:32493944-33021034</td><td>527,090</td><td>Pathogenic</td></tr><tr><td>RD_P398</td><td>Lissencephaly</td><td>Deletion</td><td>Heterozygous</td><td><italic>PAFAH1B1</italic> (exon 3–11)</td><td>chr17:2555675-2645203</td><td>89,528</td><td>Pathogenic</td></tr><tr><td>RD_P399</td><td>NMD</td><td>Deletion</td><td>Homozygous</td><td><italic>DYSF</italic> (exon 6–11)</td><td>chr2:71740967-71749805</td><td>8838</td><td>Likely pathogenic</td></tr><tr><td>RD_P400</td><td>SKD</td><td>Deletion</td><td>Heterozygous</td><td><italic>COPS7B</italic> (whole gene), <italic>NPPC</italic>, <italic>DIS3L2</italic> (exons 1–5)</td><td>chr2:232647812-232930068</td><td>282,200</td><td>Likely pathogenic</td></tr><tr><td>RD_P401</td><td>Eye disorder</td><td>Inversion</td><td>Hemizygous</td><td><italic>CHM</italic> (exon 1)</td><td>chrX:85296959-85303375</td><td>6401</td><td>Pathogenic</td></tr><tr><td>RD_P402</td><td>SKD</td><td>Deletion</td><td>Heterozygous</td><td><italic>KDM6A</italic> (whole gene)</td><td>chrX:44207077-45518941</td><td>1.3 Mb</td><td>Pathogenic</td></tr></tbody></table><table-wrap-foot><p><italic>SKD</italic> skeletal dysplasia, <italic>NMD</italic> neuromuscular disease. *Heterozygous missense in trans</p></table-wrap-foot></table-wrap>
<fig id="Fig2"><label>Fig. 2</label><caption><p>A complex DEL-INV-DEL rearrangement identified by WGS causes severe epilepsy. <bold>a</bold> Screenshot of the deletions and inversion from the Integrative Genomics Viewer (IGV) in individual RD_P393. Short-read whole-genome sequencing (WGS) detected two clustered deletions of 630 kb (<italic>SCN3A</italic>, <italic>SCN2A</italic>, <italic>CSRNP3</italic>, <italic>GALNT3</italic>) and 121 kb (<italic>SCN1A</italic>), respectively. The genomic segment of normal copy number state in-between the deletions (139 kb, <italic>TTC21B</italic>) had been inverted. Both inversion breakpoint junctions are shown with the green and blue bars corresponding to discordant reads with mates located on the other side of the inversion. <bold>b</bold> Screenshot of DEL-INV-DEL rearrangement confirmed by array comparative genomic hybridization (array-CGH). Screenshot from the Cytosure Interpret Software. The deletions in the rearrangement were confirmed using array-CGH. <bold>c</bold> Breakpoint junction sequences. Sequence analysis of the breakpoint junctions revealed insertions in both junctions of 38 bp and 59 bp, respectively (pink). Substantial parts of the insertions had been templated from sequences involved in the rearrangement (underlined), suggestive of a replicative error as the underlying mechanism of formation. L1 repetitive elements were present in two of the breakpoints but did not form any fusion L1 elements. Lowercase letters indicate deleted sequences</p></caption><graphic id="MO2" xlink:href="13073_2019_675_Fig2_HTML"></graphic></fig></p>
<sec id="Sec17">
<title>A founder duplication in LAMA2 is the cause of neuromuscular disease in two unrelated individuals</title>
<p id="Par66">An identical homozygous duplication of exon 30 in <italic>LAMA2</italic> was found in two seemingly unrelated individuals of the same ethnic origin (RD_P394, RD_P395; Table <xref ref-type="table" rid="Tab3">3</xref>) with muscular dystrophy. The duplication was not found in DGV, The Genome Aggregation Database (gnomAD) [<xref ref-type="bibr" rid="CR70">70</xref>], or the SweFreq SVDB databases. <italic>LAMA2</italic> (located on chromosome 6q22–23) consists of 65 exons and encodes the protein merosin. The WGS data showed signals consistent with a tandem duplication, which conceptually will produce one normal copy of exon 30 followed by a frameshift and a stop codon after 35 aberrant residues. Immunohistochemical antibody staining of merosin in muscle biopsies from both patients showed absence of the protein, consistent with a loss-of-function mutation and conforming to a diagnosis of autosomal recessive muscular dystrophy (MIM 607855) [<xref ref-type="bibr" rid="CR71">71</xref>].</p>
</sec>
<sec id="Sec18">
<title>A heterozygous deletion on 2q27 causes dominant skeletal dysplasia</title>
<p id="Par67">In individual RD_P400 (Table <xref ref-type="table" rid="Tab3">3</xref>), CMA and WGS analysis identified a maternally inherited 282-kb deletion on chromosome 2q27 affecting three genes, the entire <italic>COPS7B</italic>, <italic>NPPC</italic>, and exons 1–5 of <italic>DIS3L2</italic>. The patient had disproportionate short stature, brachydactyly E, and small hands and feet. Her phenotype is summarized in Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Document S2. Recently, two unrelated families were reported with heterozygous missense variants in <italic>NPPC</italic> segregating with a short stature and small hand phenotype, very similar to that of our patient and her mother, have been described [<xref ref-type="bibr" rid="CR72">72</xref>] (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Document S2). Further, <italic>NPPC</italic> plays an important role in endochondral ossification through regulation of chondrocyte proliferation and differentiation in the cartilaginous growth plate [<xref ref-type="bibr" rid="CR73">73</xref>]<italic>.</italic> It binds and stimulates the cGMP production of the NPR2 receptor and is through that pathway involved in the pathogenesis of relatively common skeletal dysplasias such as achondroplasia (MIM 100800) and acromesomelic dysplasia, Maroteaux type (MIM 602875).</p>
</sec>
<sec id="Sec19">
<title>A complex intrachromosomal rearrangement disrupting three epilepsy genes</title>
<p id="Par68">A DEL-INV-DEL rearrangement was identified by WGS in individual RD_P393, a girl with developmental delay and severe epilepsy. A detailed clinical description is available in the supplemental information (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Document S2). Due to a clinical suspicion of monogenic disease, WGS was performed and filtered for genes involved in inborn errors of metabolism as well as epilepsy without identifying a causative genetic variant. The WGS data was then analyzed for structural variants using the FindSV pipeline, and the results showed a <italic>de novo</italic> complex rearrangement on chromosome 2q24.2 including two heterozygous deletions separated by an inverted fragment. The two deletions were visible by CMA and directly affected four genes (<italic>SCN1A</italic>, <italic>SCN2A</italic>, <italic>SCN3A</italic>, and <italic>CSRNP3</italic>) (Fig. <xref ref-type="fig" rid="Fig2">2</xref>a, b, Table <xref ref-type="table" rid="Tab4">4</xref>). The proximal deletion was 628 kb, and the proximal breakpoint disrupted intron 1 of <italic>SCN3A</italic> and the distal breakpoint were located 28 kb upstream of <italic>GALNT3</italic>, with a complete heterozygous loss of <italic>GALNT3</italic>, <italic>SCN2A</italic>, and <italic>CSRNP3</italic>. The distal deletion was 121 kb, with the proximal breakpoint 28 kb downstream of <italic>SCN1A</italic> and the distal breakpoint in intron 1 of <italic>SCN1A</italic>. Finally, the 139 kb genomic segment located in-between the deletions had been inverted resulting in a DEL-INV-DEL pattern (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). Analysis of the breakpoint junctions revealed partially templated insertions of 38 bp and 59 bp, respectively (Fig. <xref ref-type="fig" rid="Fig2">2</xref>c). The insertions did not originate from the sequences in direct proximity of each junction, instead parts of the insertion in junction 1 originated from junction 2 sequences, and parts of the insertion in junction 2 originated from junction 1 sequences (Fig. <xref ref-type="fig" rid="Fig2">2</xref>c). One breakpoint disrupted <italic>SCN1A</italic> in intron 1 and another breakpoint disrupted <italic>SCN3A</italic> in intron 1, with no surrounding repetitive sequences. The remaining two breakpoints did not disrupt any protein coding genes but were located in repetitive regions belonging to the L1 family (L1MC4a and L1MA4). No L1 fusion elements were created as a result of the rearrangement.
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Clinically relevant findings in a prospective study of 100 cases referred for CMA</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>Case</td><td>Reason for referral</td><td>CNVs (ISCN 2016)</td><td>Size</td><td>Classification</td><td>OMIM diagnosis (inheritance pattern)</td><td>Added information by WGS</td></tr><tr><td colspan="7">Fifteen CNVs detected with CMA and WGS</td></tr><tr><td> RD_P403</td><td>NDD</td><td>arr[GRCh37] 2p21p22.1(39053852_42501893)x3 dn</td><td>3.45 Mb</td><td>Likely pathogenic</td><td>Not in OMIM</td><td>Tandem duplication</td></tr><tr><td> RD_P404</td><td>NDD</td><td>arr[GRCh37] 3p25.2p25.3(9453917_12015126)x3</td><td>2.56 Mb</td><td>Likely Pathogenic</td><td>Not in OMIM</td><td>Tandem duplication</td></tr><tr><td> RD_P405</td><td>Growth retardation</td><td>arr[GRCh37] 3q25.32q26.1(158567751_160802139)x3 (not paternal)</td><td>2.23 Mb</td><td>Likely Pathogenic</td><td>Not in OMIM</td><td>Duplication inserted on chromosome 13</td></tr><tr><td> RD_P406</td><td>NDD, microcephaly</td><td>arr[GRCh37] 4q25q35.2(190816609_191024533)x3 dn</td><td>81 Mb</td><td>Pathogenic</td><td>Not in OMIM</td><td>Unbalanced translocation between chr 4 and chr2</td></tr><tr><td> RD_P407</td><td>NDD, Arthrogryposis</td><td><p>arr[GRCh37]</p><p>7q11.23(72699382_74142329)x1 dn</p></td><td>1.44 Mb</td><td>Pathogenic</td><td><p>#194050</p><p>Williams-Beuren syndrome (AD)</p></td><td></td></tr><tr><td> RD_P408</td><td>Short stature, NDD, facial dysmorphism</td><td><p>arr[GRCh37]</p><p>7q11.23(72726590_74142329)x1 dn</p></td><td>1.42 Mb</td><td>Pathogenic</td><td><p>#194050</p><p>Williams-Beuren syndrome (AD)</p></td><td></td></tr><tr><td> RD_P409</td><td>Hypogonadotropic hypogonadism</td><td><p>arr[GRCh37]</p><p>8p11.22(38320755_38328265)x1 dn (exon 1 <italic>FGFR1</italic>)</p></td><td>7.52 kb</td><td>Pathogenic</td><td>#147950 Kallmann syndrome (AD)</td><td></td></tr><tr><td> RD_P410</td><td>Duodenal atresia</td><td>arr[GRCh37] 9p24.2p24.3(2074076_2381053)x1 pat</td><td>307 kb</td><td>VUS</td><td>Not in OMIM</td><td></td></tr><tr><td> RD_P411</td><td>NDD, Arthrogryposis</td><td>arr[GRCh37] 12q13.13(53784698_54741363)x1 dn</td><td>957 kb</td><td>Pathogenic</td><td>Not in OMIM</td><td></td></tr><tr><td> RD_P412</td><td>NDD</td><td>arr[GRCh37] 15q13.2q13.3(30405535_32914190)x1</td><td>2.5 Mb</td><td>Pathogenic</td><td><p>#612001</p><p>15q13.3 microdeletion syndrome (AD)</p></td><td></td></tr><tr><td> RD_P413</td><td>NDD</td><td><p>arr[GRCh37]</p><p>16p11.2(29656717_30158469)x1</p></td><td>502 kb</td><td>Pathogenic</td><td><p>#611913</p><p>16p11.2 microdeletion syndrome (AD)</p></td><td></td></tr><tr><td> RD_P414</td><td>NDD</td><td><p>arr[GRCh37]</p><p>18p11.32pter(12774-1652788)x1 dn,</p><p>18q22.1qter(62984563_78015117)x1 dn</p><p>(Ring chromosome)</p></td><td><p>1.64 Mb</p><p>15 Mb</p></td><td>Pathogenic</td><td>Not in OMIM</td><td>Detailed structure of derivative chromosome</td></tr><tr><td> RD_P415</td><td>NDD</td><td>arr[GRCh37] 22q11.21(18890264_21540347)x1</td><td>2.65 Mb</td><td>Pathogenic</td><td><p>#188400</p><p>DiGeorge syndrome (AD)</p></td><td></td></tr><tr><td> RD_P416</td><td>NDD</td><td><p>arr[GRCh37] 2q23.1(148893848_148944832)x1</p><p>(exon 3 <italic>MBD5</italic>)</p></td><td>51 kb</td><td>VUS</td><td><p>#156200</p><p>Intellectual disability 1 (AD)</p></td><td></td></tr><tr><td colspan="7">One CNV detected with WGS</td></tr><tr><td> RD_P417</td><td>NDD</td><td>arr[GRCh37] 12q24.31(123736705_123740392)x0 (exon 2 <italic>C12orf65</italic>)</td><td>3.7 kb</td><td>Pathogenic</td><td><p>#613559</p><p>Combined oxidative phosphorylation deficiency 7 (AR)</p></td><td>Deletion found by WGS and not detected by CMA</td></tr><tr><td>Case</td><td>Reason for referral</td><td>SNV</td><td>Inheritance</td><td>Zygosity</td><td>OMIM diagnosis</td><td>Classification</td></tr><tr><td colspan="7">Nine SNVs detected with ID <italic>in silico</italic> gene panel</td></tr><tr><td> RD_P418</td><td>NDD, macrocephaly</td><td><italic>NSD1</italic>, NM_172349, c.5289G&gt;C, p.(Trp1763Cys)</td><td>
<italic>De novo</italic>
</td><td>Heterozygous</td><td><p>#117550</p><p>Sotos syndrome (AD)</p></td><td>Likely Pathogenic</td></tr><tr><td> RD_P419</td><td>NDD (father with similar symptoms)</td><td><italic>NKX2</italic>-1, NM_003317, c.556delC, p.(Leu186CysfsTer12)</td><td>Paternal</td><td>Heterozygous</td><td><p>#610978</p><p>Choreoathetosis, hypothyroidism and neonatal respiratory distress (AD)</p></td><td>Likely Pathogenic</td></tr><tr><td rowspan="2"> RD_P420</td><td rowspan="2">NDD, white matter abnormality</td><td rowspan="2"><p><italic>PNPT1</italic>, NM_033109, c.420delG; p.(Leu141SerfsTer17)</p><p><italic>PNPT1</italic>, NM_033109, c.1519G&gt;T, p.(Ala507Ser)</p></td><td>Paternal</td><td rowspan="2">Compound heterozygous</td><td rowspan="2"><p>#614932</p><p>Combined oxidative phosphorylation deficiency 13 (AR)</p></td><td rowspan="2">Likely Pathogenic</td></tr><tr><td>Maternal</td></tr><tr><td> RD_P421</td><td>NDD, cleft-lip palate</td><td><italic>SATB2</italic>, NM_015265, c.652A&gt;T, p.(Lys218Ter)</td><td>
<italic>De novo</italic>
</td><td>Heterozygous</td><td><p>#612313</p><p>Glass syndrome (AD)</p></td><td>Pathogenic</td></tr><tr><td> RD_P422</td><td>Microcephaly, holoprocencephaly</td><td><italic>ZIC1</italic>, NM_007129, c.1225C&gt;T, p.(Arg409Trp)</td><td>
<italic>De novo</italic>
</td><td>Heterozygous</td><td><p>#616602</p><p>Craniosynostosis 6 (AD)</p></td><td>Likely Pathogenic</td></tr><tr><td> RD_P423</td><td>NDD, macrocephaly</td><td><italic>PTEN</italic>; NM_000314, c.264T&gt;G; p.(Tyr88Ter)</td><td>N.i.</td><td>Heterozygous</td><td><p>#158360</p><p>Cowden syndrome (AD)</p></td><td>Likely Pathogenic</td></tr><tr><td> RD_P424</td><td>Respiratory failure, abnormality of corpus callosum</td><td><italic>POLG</italic>; NM_002693, c.679C&gt;T;679C&gt;T, p.(Arg227Trp)</td><td><p>Paternal/</p><p>Maternal</p></td><td>Homozygous</td><td><p>#203700</p><p>Mitochondrial DNA depletion syndrome 4A (AR)</p></td><td>Likely Pathogenic</td></tr><tr><td> RD_P425</td><td>NDD, epilepsy</td><td><italic>CLN5</italic>, NM_006493, c.595C&gt;T;595C&gt;T, p.(Arg199Ter)</td><td><p>Paternal/</p><p>Maternal</p></td><td>Homozygous</td><td><p>#256731</p><p>Ceroid lipofuscinosis, neuronal 5 (AR)</p></td><td>Pathogenic</td></tr><tr><td> RD_P426</td><td>NDD, dysmorphic features , macrocephaly</td><td><italic>ANKRD11</italic>; NM_013275, c.3882_3885dupAGAC, p.(Ser1296ArgfsTer5)</td><td>N.i.</td><td>Heterozygous</td><td><p>#148050</p><p>KBG syndrome (AD)</p></td><td>Likely Pathogenic</td></tr><tr><td colspan="7">Four SNVs detected with HPO terms-generated <italic>in silico</italic> gene panel</td></tr><tr><td> RD_P427</td><td>NDD, hypotonia, dysmorphic features</td><td><italic>TBCK</italic>, NM_033115, c.469+1G&gt;A;469+1G&gt;A</td><td><p>Paternal/</p><p>Maternal</p></td><td>Homozygous</td><td><p>#616900</p><p>Infantile hypotonia with psychomotor retardation and characteristic facies 3 (AR)</p></td><td>Pathogenic</td></tr><tr><td rowspan="2"> RD_P428</td><td rowspan="2">Arthrogryposis, dysmorphic features</td><td rowspan="2"><p><italic>ECEL1</italic>, NM_004826, c.494T&gt;C, p.(Leu165Pro)</p><p><italic>ECEL1</italic>, NM_004826, c.2228G&gt;T, p.(Arg743Met)</p></td><td>Not maternal</td><td rowspan="2">Compound heterozygous</td><td rowspan="2"><p>#615065</p><p>Distal arthrogryposis type 5D (AR)</p></td><td rowspan="2">VUS</td></tr><tr><td>Maternal</td></tr><tr><td> RD_P429</td><td><p>Hypotonia,</p><p>hearing loss</p></td><td><italic>ACOX1</italic>, NM_004035, c.1729-1G&gt;A</td><td>Paternal/Maternal</td><td>Homozygous</td><td><p>#264470</p><p>Peroxisomal acyl-CoA oxidase deficiency (AR)</p></td><td>Likely pathogenic</td></tr><tr><td rowspan="2"> RD_P430</td><td rowspan="2">Hypertrophic cardiomyopathy, severe anemia, respiratory failure</td><td rowspan="2"><p><italic>SPTA1,</italic> NM_003126, c.83G&gt;A, p.(Arg28His)</p><p><italic>SPTA1,</italic> NM_003126, c.47854delG, p.(Arg1595Lysfs*38)</p></td><td>Paternal</td><td rowspan="2">Compound heterozygous</td><td rowspan="2"><p>#270970</p><p>Spherocytosis type 3 (AR)</p></td><td rowspan="2">Pathogenic</td></tr><tr><td>Maternal</td></tr><tr><td colspan="7">Repeat expansions detected by WGS</td></tr><tr><td> RD_P431</td><td>Hypotonia, ASD, metabolic acidosis</td><td><italic>ATXN7</italic>, STR</td><td>N.i.</td><td>Heterozygous</td><td><p>#164500</p><p>Spinocerebellar ataxia 7 (AD)</p></td><td>Pathogenic</td></tr><tr><td colspan="7">Uniparental isodisomy validated by WGS</td></tr><tr><td> RD_P432</td><td>Hypotonia, dysmorphic features</td><td>Maternal UPD 15 (isodisomy)</td><td>N.a.</td><td>N.a.</td><td><p>#176270</p><p>Prader-Willi syndrome (AD)</p></td><td>Pathogenic</td></tr></tbody></table><table-wrap-foot><p><italic>CNV</italic> copy number variant, <italic>CMA</italic> chromosomal microarray, <italic>NDD</italic> neurodevelopmental delay, <italic>WGS</italic> whole-genome sequencing, <italic>VUS</italic> variant of uncertain significance, <italic>SNV</italic> single nucleotide variant, <italic>STR</italic> short tandem repeat, <italic>N.i.</italic> no information, <italic>UPD</italic> uniparental disomy, <italic>N.a.</italic> not applicable, <italic>AD</italic> autosomal dominant, <italic>AR</italic> autosomal recessive</p></table-wrap-foot></table-wrap></p>
<p id="Par69">To summarize, this individual is a carrier of a structural variant that leads to loss of function in three distinct Mendelian epilepsy genes. Both deletions and duplications, involving each of <italic>SCN1A</italic>, <italic>SCN2A</italic>, and <italic>SCN3A</italic>, have been presented previously in cases with severe epileptic encephalopathies and developmental delay [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. In the case presented here, the deletions disrupted <italic>SCN1A</italic> and <italic>SCN3A</italic> and resulted in a complete loss of <italic>SCN2A</italic> (Fig. <xref ref-type="fig" rid="Fig2">2</xref>, Table <xref ref-type="table" rid="Tab3">3</xref>, Table <xref ref-type="table" rid="Tab4">4</xref>). The clinical presentation is coherent with Dravet syndrome (MIM 607208), usually caused by mutations involving <italic>SCN1A</italic>; however, the phenotypic variability in <italic>SCN1A</italic> mutation carriers is wide [<xref ref-type="bibr" rid="CR76">76</xref>]. In addition, mutations in <italic>SCN2A</italic> also cause epileptic encephalopathy (MIM 613721) and missense variants in <italic>SCN3A</italic> have been implicated in focal epilepsy in children [<xref ref-type="bibr" rid="CR77">77</xref>].</p>
</sec>
</sec>
<sec id="Sec20">
<title>Prospective study of comprehensive WGS analysis in 100 cases referred for CMA</title>
<p id="Par70">Finally, we performed a prospective pilot study where the first 100 cases referred to the Department of Clinical Genetics (Karolinska University Hospital, Stockholm, Sweden) for CMA in 2017 were analyzed in parallel with WGS. The obtained WGS data were processed for large SVs (&gt; 10 kb), for genome-wide and small SVs (&gt; 2 kb), and for SNVs and INDELs in 887 genes linked to intellectual disability (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Document S1). For individuals with additional clinical symptoms, custom <italic>in silico</italic> gene panels were created using HPO terms and data were processed for small SVs in the same way as for the ID gene panel. Next, small (&gt; 2 kb) intragenic SVs were assessed in the both gene panels. Finally, we applied the ExpansionHunter analysis pipeline [<xref ref-type="bibr" rid="CR30">30</xref>] to identify large expansions of STRs in 17 genes.</p>
<sec id="Sec21">
<title>Detection of copy number variants</title>
<p id="Par71">The CMA analysis identified, in 14 patients, a total of 15 CNVs that were classified as pathogenic (<italic>n</italic> = 10), likely pathogenic (<italic>n</italic> = 3), and variants of uncertain significance (VUS) (<italic>n</italic> = 2) (Table <xref ref-type="table" rid="Tab4">4</xref>). Six rearrangements were recurrent known microdeletion syndromes: 7q11.23 deletions (RD_P407, RD_P408), 8p11.22 deletion (RD_P409), 15q13.2q13.3 deletion (RD_P412), 16p11.2 deletion (RD_P413), and 22q11.21 deletion (RD_P415) while the remainder were non-recurrent/private rearrangements. All of these CNVs were also detected by WGS. In addition, in individual RD_P417, the WGS-SV analysis detected a 3.7-kb homozygous deletion of exon 2 in <italic>C12orf65</italic> confirming a diagnosis of autosomal recessive spastic paraplegia 55 (SPG55) (MIM 615035) (Table <xref ref-type="table" rid="Tab4">4</xref>). This deletion was not called by CMA due to insufficient probe coverage (no probes within the deleted regions).</p>
</sec>
<sec id="Sec22">
<title>Comparison of WGS-SVs to CNVs detected by CMA</title>
<p id="Par72">After the array-CGH data was analyzed with standard clinical setting (three consecutive aberrant probes; log2 ratio cutoff − 0.65 for deletions and 0.35 for duplications), a total of 2282 deletions and duplications were called in the 100 patients in cohort 3 (Additional file <xref ref-type="media" rid="MOESM3">3</xref>: Table S2). The median number of CNV calls was 22 (quantile (Q)1 18; Q3 26) with a median size of 51 kb (Q1 24 kb; Q3 122 kb). The corresponding numbers from WGS, after filtering for size (&gt; 10 kb intergenic, and &gt; 2 kb intergenic) and frequency (&lt; 0.5% AF in SweFreq SVDB, &lt; 1% in the internal SVDB), were a median number of 28 (Q1 20; Q3 36) and the median size of 17 kb (Q1 6 kb; Q3 70 kb). Comparison of the output data files show that the filtered WGS-SVs only overlap with 9.1% of the CMA calls (208/2282), and if we remove the frequency filter, the overlap increases 34.8% (794/2282) (Table S2). The CMA variants not detected by WGS were smaller, median 38 kb (Q1 19kb, Q3 98kb), compared to those also found with WGS, median 84 kb (Q1 41kb, Q3 154kb). In addition, the percentage of duplications among the CMA variants found by WGS was 52% versus 75% among the variants not found by WGS.</p>
</sec>
<sec id="Sec23">
<title>WGS reveals the presence of derivative chromosomes and solves their genomic structure</title>
<p id="Par73">In case RD_P414, the investigations with CMA identified two deletions on chromosome 18: 1.64 Mb on the terminal p-arm and 15 Mb on the terminal q-arm. Follow-up investigation with chromosome analysis showed that the rearrangement was in fact a ring chromosome present in 100% of the cells. In the same individual, blinded WGS analysis was able to detect the two deletions, characterize the rearrangement breakpoint junctions, and fully resolve the derivative chromosome structure (Fig. <xref ref-type="fig" rid="Fig3">3</xref>, Table <xref ref-type="table" rid="Tab4">4</xref>, Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S4).
<fig id="Fig3"><label>Fig. 3</label><caption><p>Three cases with complex genomic rearrangements resolved by WGS. <bold>a</bold> A schematic drawing of the 4q25q35.2 unbalanced translocation in individual RD_P406. The duplicated segment of 81 kb (green) is inserted into the p-arm of chromosome 2 directly before the telomeric sequences. A 27-kb deletion on chromosome 2 (orange) is visible in the WGS data. The dashed line represents the links from chromosome 4 to chromosome 2. To the right, the insertional duplication rearrangement is shown through karyotyping with the derivative chromosome 2 indicated by a red arrow. <bold>b</bold> A schematic drawing of the 3q25.32q26.1 insertional duplication in individual RD_P405 as in <bold>a</bold>. The duplicated segment of 2.23 Mb is inserted into chromosome 13, and a genomic segment of 69.6 kb on chromosome 13, adjacent to the insertion, has been inverted. To the right, FISH analysis using probes RP11-209H21SG (green) and RP11-203L15SO (red) located within the rearranged region on chromosome 3. In addition to two signals from chr 3q25.32q26.1, an extra signal is present on chromosome 13 (white arrow) verifying the location of the duplicated segment. <bold>c</bold> A schematic drawing of the r(18) present in individual RD_P414 as in <bold>a</bold>. To the right, the ring chromosome is shown through karyotyping</p></caption><graphic id="MO3" xlink:href="13073_2019_675_Fig3_HTML"></graphic></fig></p>
<p id="Par74">In two cases harboring duplications, the WGS analysis not only detected the presence of a duplication but also revealed that one duplication was part of a cryptic unbalanced translocation and the other was an insertional translocation. In individual RD_P406, an 81-Mb terminal duplication (4q25qter) had been inserted onto the p-arm of chromosome 2 directly before the telomeric sequences. WGS also uncovered a 27-kb deletion on 2p25.3pter not seen by CMA indicating that this was in fact an unbalanced translocation between chromosome 4q and chromosome 2p (Fig. <xref ref-type="fig" rid="Fig3">3</xref>, Table <xref ref-type="table" rid="Tab4">4</xref>, Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S4). The breakpoint junction had a four-nucleotide non-templated insertion in the junction, and sequence microhomology was low.</p>
<p id="Par75">In individual RD_P405, a 2.23-Mb duplication of 3q25.32q26.1 was inserted into chromosome 13 (13q31.1). In addition, it was found that there were two breakpoints on chromosome 13, the genomic segment of 69.6 kb between them had been inverted, and the duplication originating from 3q25.32q26.1 was inserted into the proximal breakpoint junction. This was only detected through WGS (Fig. <xref ref-type="fig" rid="Fig3">3</xref>). A total of three breakpoint junctions were identified in this patient, and the junctions showed little to no microhomology, no insertions, and no deletions (Table <xref ref-type="table" rid="Tab4">4</xref>, Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S4).</p>
<p id="Par76">Taken together, the breakpoint junctions from both patients harboring insertional duplications revealed no evidence for DNA replication errors, which has been the proposed mechanism underlying the formation of duplications in several cases [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR79">79</xref>].</p>
<p id="Par77">In summary, three out of 100 individuals (3%) with intellectual disability referred for CMA carried derivative chromosomes with additional complexities detected and resolved by WGS.</p>
</sec>
<sec id="Sec24">
<title>Single nucleotide variation</title>
<p id="Par78">The WGS data was next processed for SNVs and INDELs in a panel of 887 genes (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Document S1) as well as in custom panels created from HPO terms matching the individual patients’ phenotypes. This way, heterozygous SNVs implicated in autosomal dominant disease were identified in six patients (6%), of which five were classified as likely pathogenic and one as pathogenic. Compound heterozygous or homozygous SNVs implicated in autosomal recessive disease were identified in seven patients (7%), of which one was classified as VUS, three as likely pathogenic and three as pathogenic. No X-linked variants were identified (Table <xref ref-type="table" rid="Tab4">4</xref>).</p>
</sec>
<sec id="Sec25">
<title>WGS diagnoses a lethal form of ataxia type 7 through a repeat expansion in ATXN7</title>
<p id="Par79">Next, we assessed the presence of STRs in 17 genes. A likely pathogenic repeat expansion in <italic>ATXN7</italic> was identified in individual RD_P431 (Table <xref ref-type="table" rid="Tab4">4</xref>). In brief, this was the second child born to unrelated parents. She was treated in the intensive care unit due to hypotonia, cardiac failure, and metabolic acidosis and died at the age of 10 months. The father had poor vision and balance problems but no molecular diagnosis. The detailed clinical description is available in the supplemental information (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Document S2). WGS was performed and filtered for genes involved in inborn errors of metabolism without identifying a causative genetic variant. Upon reanalysis of this case, no suspected pathogenic SNV, INDEL, or SV was identified. However, both FindSV (TIDDIT) and ExpansionHunter indicated an aberrant signal from the <italic>ATXN7</italic> locus. The presence of a CAG STR was confirmed using PCR with fragment length analysis including triplet primed PCR. The detected number of repeated CAG units was 233 in individual RD_P431 and 46 in the father confirming the diagnosis of Spinocerebellar ataxia 7 (SCA7) in both (MIM 164500) (Fig. <xref ref-type="fig" rid="Fig4">4</xref>).
<fig id="Fig4"><label>Fig. 4</label><caption><p>A short tandem repeat expansion in <italic>ATXN7</italic> is identified by WGS. <bold>a</bold> The pedigree and number of <italic>ATXN7</italic> CAG repeats are illustrated under each individual. <bold>b</bold> The PCR-amplified CAG-repeat data from the father shows one normal sized allele and one expanded allele (top chromatogram). In the bottom chromatogram, the results from the affected child are shown. <bold>c</bold> Integrative Genomics Viewer (IGV) screenshot of the data obtained from FindSV shows the first indication of an <italic>ATXN7</italic> abnormality. The aberrant signal was initially interpreted by the program as an insertion of sequence from chromosome 18 (right) into <italic>ATXN7</italic> (left)</p></caption><graphic id="MO4" xlink:href="13073_2019_675_Fig4_HTML"></graphic></fig></p>
</sec>
<sec id="Sec26">
<title>Maternal isodisomy is visible in the WGS data</title>
<p id="Par80">Genomic DNA from individual RD_P432 (from cohort 3) was analyzed with methylation-specific MLPA that showed a methylation pattern in the 15q11.2q13 region consistent with a diagnosis of Prader-Willi syndrome (MIM 176270). Genotyping of 10 polymorphic markers located across chromosome 15 (from 22.9 to 49.3 Mb) in the patient and her mother suggested the presence of chromosome 15 maternal uniparental disomy (UPD) for the region 22.9–33.7 Mb. We were able to confirm this finding by assessing the B-allele frequency of SNPs on chromosome 15 in the WGS data. This analysis also confirmed that this was a case of segmental isodisomy (Fig. <xref ref-type="fig" rid="Fig5">5</xref>, Table <xref ref-type="table" rid="Tab4">4</xref>).
<fig id="Fig5"><label>Fig. 5</label><caption><p>Prader-Willi syndrome caused by maternal isodisomy. Homozygosity for SNPs on chromosome 15 from WGS data in individual RD_P432. The fraction of homozygous SNPs is shown on the Y axis and the position on chromosome 15 on the X axis. The position of <italic>SNRPN</italic> is indicated with an arrow. Each gray dot represents the fraction of homozygous SNVs in 10 kb regions. The green line indicates the fraction of homozygous SNV across the entire chromosome, and red lines indicate autozygous regions predicted by rhocall</p></caption><graphic id="MO5" xlink:href="13073_2019_675_Fig5_HTML"></graphic></fig></p>
<p id="Par81">Excluding the variants classified as VUS, the diagnostic yield in 100 unselected cases referred for CMA was 27% compared to 12% with array only (Fig. <xref ref-type="fig" rid="Fig6">6</xref>).
<fig id="Fig6"><label>Fig. 6</label><caption><p>Genetic architecture of a mixed cohort referred for diagnostic analysis. Each slice of the pie chart represents one individual in the 100 prospective cases analyzed by both chromosomal microarray (CMA) and whole-genome sequencing (WGS) where a causal genetic variant was identified. Type of variants is indicated by colors (UPD, red; repeat expansion, orange; homozygous deletion, light green; heterozygous deletion, dark green; duplication, purple; compound heterozygous SNV, light blue; homozygous SNV, blue; heterozygous SNV, dark blue). Additional complexity is indicated by a * and CNVs detected by WGS first with a ¤</p></caption><graphic id="MO6" xlink:href="13073_2019_675_Fig6_HTML"></graphic></fig></p>
</sec>
</sec>
</sec>
<sec id="Sec27">
<title>Discussion</title>
<p id="Par82">Previous studies have suggested that short-read WGS could be a first-level test in individuals with neurodevelopmental delay and intellectual disability [<xref ref-type="bibr" rid="CR80">80</xref>]. Here we show that WGS with regular coverage (30×) indeed captures the complex genetic variation underlying rare diseases in an unselected mixed cohort referred for genetic testing. Altogether, we found that 27% of these individuals harbored clinically relevant genetic variants that could be detected by WGS. In addition, the WGS analysis provided clinically important information by resolving the structure of the derivative chromosomes and revealing additional complexities.</p>
<p id="Par83">Our data demonstrates that short-read WGS performs well for CNV detection from small intragenic variants to large chromosomal rearrangements. By applying multiple callers with complementary characteristics [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>], we successfully detected all 92 known SVs in our three cohorts as well as 11 previously undetected events. We previously compared the performance of the SV callers TIDDIT [<xref ref-type="bibr" rid="CR46">46</xref>], Manta [<xref ref-type="bibr" rid="CR81">81</xref>], CNVnator [<xref ref-type="bibr" rid="CR45">45</xref>], DELLY [<xref ref-type="bibr" rid="CR82">82</xref>], Fermikit [<xref ref-type="bibr" rid="CR83">83</xref>], and Lumpy [<xref ref-type="bibr" rid="CR84">84</xref>] and found that TIDDIT and CNVnator are complementary and offer high precision and sensitivity on large SV [<xref ref-type="bibr" rid="CR46">46</xref>]. This was confirmed by a recent evaluation of the performance of 69 SV detection algorithms including TIDDIT and CMVnator [<xref ref-type="bibr" rid="CR85">85</xref>]. Therefore, we chose to combine the TIDDIT and CNVnator callers, enabling the detection of a wide range of variants while using a limited amount of computational resources. Overall, CNVnator [<xref ref-type="bibr" rid="CR45">45</xref>] failed to detect five aberrations: three deletions (RD_P62, RD_P63, RD_P64) and two duplications (RD_P123, RD_P139) all below 8 kb in size (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1). This highlights that the coverage analysis has limitations in detecting such small CNVs. In contrast, TIDDIT [<xref ref-type="bibr" rid="CR46">46</xref>] successfully identified all those small CNVs but were unable to call the recurrent events (<italic>n</italic> = 16). This is explained by the mechanism underlying the formation of those rearrangements, non-allelic homologous recombination between repeat structures flanking the CNV. Hence, the breakpoint junctions cluster in those repeats, and since TIDDIT uses split reads and discordant pairs to call an event, the read length (151 bp) and insert size (~ 350 bp) of short-read WGS are not enough to bridge the repetitive regions.</p>
<p id="Par84">Of note, effective SV screening from WGS is highly dependent on the availability of high-quality frequency databases representing population background variation (and sequencing artifacts) which are essential for the selection of rare potentially disease-causing variants. We filtered the data against our internal database of ~ 400 individuals as well as the SV database from the 1000 Swedish genomes [<xref ref-type="bibr" rid="CR6">6</xref>] that were analyzed with the same bioinformatic tools used here. After filtering for size (&gt; 10 kb genome wide and &gt; 2 kb in target genes) and frequency (SweFreq SVDB &lt; 0.5%, internal SVDB &lt; 1%), we ended up with a manageable number of SV calls (median 38, average 54; standard deviation 48) that were moved forward to clinical interpretation. The standard deviation could be explained by some individuals of non-Swedish origin and sequencing quality.</p>
<p id="Par85">The other main obstacle hampering the utility of WGS for SV screening in routine clinical diagnostics is visualization of the structural variants called by WGS. To overcome this, we developed vcf2cytosure [<xref ref-type="bibr" rid="CR56">56</xref>], a program that converts VCF files with structural variations to the “.CGH” format. The output files are subsequently uploaded into the CytoSure Interpret Software, generally used for visualization of array-CGH data at our clinic (examples of output data visualized in this way are shown in the supplemental data; Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Fig. S3). Through this approach, we facilitated the clinical interpretation of the WGS-SV data by non-bioinformaticians.</p>
<p id="Par86">The 15 additional diagnoses provided by WGS compared to CMA included one homozygous exonic deletion, one STR, one UPD, and 12 SNVs (six heterozygous, four homozygous, and two compound heterozygous) (Table <xref ref-type="table" rid="Tab4">4</xref>). In all cases, obtaining a diagnosis will have an immediate impact by providing more accurate information to the 15 families, enabling both carrier detection and prenatal testing. Embryo diagnostics will be possible for the nine couples with a high recurrence risk; seven with autosomal recessive cause of disease and two with autosomal dominant. In several cases, the molecular diagnosis leads to improved patient care and management, such as the father of RD_P431 with SCA7, and for others, the number of necessary hospital visits was decreased.</p>
<p id="Par87">In aggregate, our data show that WGS has the potential to be a single test for the detection of the many different genetic variation types underlying rare diseases. However, for each variant class (SVs, SNVs, STRs, ROH, and mosaic events), it is important to understand the limitations of the test. For the calling of SNVs and INDELs, WGS has already shown high sensitivity and specificity [<xref ref-type="bibr" rid="CR86">86</xref>], but both SVs, STR, and ROH analysis need to be further studied in larger cohorts. Hence, due to a lack of data on sensitivity and specificity of WGS for calling SVs, STRs, and ROH, it is important to remember that a normal result is still hard to interpret and we suggest that all such cases are clinically assessed and if necessary, offered additional testing.</p>
<p id="Par88">Our evaluation here of WGS-SV analysis in a clinical setting has provided several important insights. First, the detection of 107 disease-causing CNVs (Table <xref ref-type="table" rid="Tab2">2</xref>, Table <xref ref-type="table" rid="Tab3">3</xref>, Table <xref ref-type="table" rid="Tab4">4</xref>, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1) illustrates that WGS can be used to detect disease-causing CNVs of different sizes and types. Second, comparing the WGS-SVs in cohort 3 to all the CNVs called by CMA in the same individuals, we find that the two methods not only produce different amounts of variants but also that only one third of the polymorphic CNVs called by CMA are present in the WGS files (Additional file <xref ref-type="media" rid="MOESM3">3</xref>: Table S2). This is problematic, however, we cannot be entirely sure as to which calls are true, since the WGS data is compared to array-CGH data which is derived from relative quantification. Furthermore, the CMA calls not detected by WGS are smaller (median 38 kb vs 84 kb for CNVs detected by WGS) and prone towards duplications (75% vs 52% in CNVs detected by WGS) supporting the notion that these are indeed technical artifacts in the CMA data.</p>
<p id="Par89">The data presented here also illustrate that screening for STRs and ROH using WGS is a feasible and fruitful approach increasing the number of patients with a definite molecular diagnosis. We consider it clinically relevant to perform these analyses in patients with unexplained intellectual disability. Clinical labs already perform targeted testing for the <italic>FMR1</italic> repeat expansion (FRAX, MIM 309548) and UPD 15 (Angelman syndrome, MIM 105830; Prader-Willi syndrome, MIM 176270) in such cases. If this information is obtainable in the WGS data, it should also be analyzed.</p>
<p id="Par90">The mosaic trisomy 9 in individual RD_P167 show similar levels of mosaicism by CMA and WGS, and the discrepancy with FISH is likely a culture artifact. The sensitivity of WGS to detect mosaicism still needs to be further evaluated and will most likely depend on the coverage, the caller(s) used, and the specific chromosome affected. Both size and quality of the reference genome as well as GC content will most likely influence the performance. In a previous publication, we assessed the detection rate of a simulated trisomy X and show that it can be detected confidently down to 10% with 30× WGS [<xref ref-type="bibr" rid="CR67">67</xref>].</p>
<p id="Par91">The diagnostic yield obtained here (27%) using WGS as a first-tier diagnostic test should be compared to previous studies obtaining over 30% diagnostic yield after SNV analysis of WES data [<xref ref-type="bibr" rid="CR17">17</xref>]. Since WGS is free from the capture biases that may affect WES and offers the possibility to detect more types of variants (i.e., balanced chromosomal rearrangements, small CNVs affecting single exons, repeat expansions, and deep splice variants), one might expect a higher diagnostic yield. However, the diagnostic yield of WES may range from 8 [<xref ref-type="bibr" rid="CR87">87</xref>] to 60% [<xref ref-type="bibr" rid="CR88">88</xref>], depending on the selection criteria and whether proband-only or familial WES was performed [<xref ref-type="bibr" rid="CR15">15</xref>]. Here we studied a randomly selected cohort of 100 individuals referred for CMA to our center and we only sequenced the probands. After this first screening analysis, the negative cases with a high probability of a genetic cause may be offered trio WGS analysis. In this way, we expect the diagnostic yield to rise, mainly due to an increased detection rate of <italic>de novo</italic> missense mutations in known disease-causing genes but also due to a higher power to detect variation in new undescribed disease-causing genes as well as in non-exonic regions of established genes.</p>
<p id="Par92">As has been shown previously [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR89">89</xref>, <xref ref-type="bibr" rid="CR90">90</xref>], our data confirms the notion that structural variants are important contributors also to Mendelian diseases (12/156, 7.7%). The <italic>LAMA2</italic> duplication identified in RD_P394 and RD_P395 may represent a founder mutation. As we assess structural variation in more individuals, both healthy and clinically affected, the true frequency of rare founder SVs will also be revealed. This is important and needs to be taken into consideration as we transition to whole-genome diagnostic sequencing.</p>
<p id="Par93">Several cases in the three studied cohorts harbored known or unexpected complex structural variants. The high accuracy of WGS allowed us to map the breakpoint junctions with nucleotide resolution and study mutational signatures. In the validation cohort, in addition to eight cases of complex intrachromosomal rearrangements that were reported previously [<xref ref-type="bibr" rid="CR68">68</xref>], a 9.3-Mb de novo deletion on chromosome 4 detected in individual RD_P77 was in fact part of a reciprocal translocation between chromosomes 4 and 7 (Fig. <xref ref-type="fig" rid="Fig1">1</xref>; Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1, Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Document S2). The breakpoint junction analysis revealed no microhomology and non-templated insertions of random nucleotides, indicative of NHEJ repair of double-strand breaks. The complex 2q24.3 rearrangement involving three Mendelian epilepsy genes identified in individual RD_P393 (Fig. <xref ref-type="fig" rid="Fig2">2</xref>, Table <xref ref-type="table" rid="Tab3">3</xref>) showed templated insertions in both breakpoint junctions, causing two small segments of 11 bp and 13 bp each to be duplicated. The mutational signatures suggest a replicative error as the mechanism of formation, such as fork stalling and template switching (FoSTeS) [<xref ref-type="bibr" rid="CR91">91</xref>]. Finally, in the 100 individuals included in the prospective cohort, one ring chromosome (RD_P414) one unbalanced translocation (RD_P406), and one insertional translocation (RD_P405) were resolved (Fig. <xref ref-type="fig" rid="Fig3">3</xref>). Each one of the three cases is of a distinct type, and no conclusive underlying mechanism was highlighted from the breakpoint junction analysis.</p>
<p id="Par94">The ability to outline structural rearrangement connectivity pictures also adds support for the use of WGS as a first-line test in intellectual disability. We have shown previously that this information is important for a proper interpretation of intragenic duplications [<xref ref-type="bibr" rid="CR78">78</xref>] as well as complex genomic rearrangements (CGRs) [<xref ref-type="bibr" rid="CR68">68</xref>]. CGRs were a common finding in all three cohorts (8/68; 1/156; 3/100) highlighting that in cases with a genetic disease caused by an SV, the probability of detecting a complex rearrangement is substantial; 12/96 SVs were detected in all three cohorts (12.5%) (Table <xref ref-type="table" rid="Tab2">2</xref>, Table <xref ref-type="table" rid="Tab3">3</xref>, Table <xref ref-type="table" rid="Tab4">4</xref>, Table <xref ref-type="table" rid="Tab5">5</xref>). In a cohort of 100 patients with intellectual disabilities not previously studied by any technique, WGS detected derivative chromosomes accompanied by additional complexities in 3%. Even in individuals with clinical symptoms not expected to be caused by CNVs (such as the cases in cohort 2), the probability is not negligible (0.6%). This type of information would not be provided by most other technologies including CMA.
<table-wrap id="Tab5"><label>Table 5</label><caption><p>Complex rearrangements detected in the current study</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Case</th><th>Cohort</th><th>Type</th><th>Chromosome(s)</th><th>Phenotype</th></tr></thead><tbody><tr><td>RD_P22</td><td>Cohort 1</td><td>DEL-NML-DEL</td><td>5</td><td>NDD</td></tr><tr><td>RD_P54</td><td>Cohort 1</td><td>DEL-INV-DEL</td><td>17</td><td>NDD</td></tr><tr><td>RD_P07</td><td>Cohort 1</td><td>DEL-NML-DEL-NML-DUP</td><td>1</td><td>NDD+</td></tr><tr><td>RD_P05</td><td>Cohort 1</td><td>DEL-DUP-DEL</td><td>2</td><td>Internal malformations</td></tr><tr><td>RD_P26</td><td>Cohort 1</td><td>DEL-INV-DEL</td><td>21</td><td>NDD+</td></tr><tr><td>RD_P105</td><td>Cohort 1</td><td>DUP-NML-DUP</td><td>7</td><td>NDD</td></tr><tr><td>RD_P106</td><td>Cohort 1</td><td>DUP-NML-DUP</td><td>14</td><td>NDD</td></tr><tr><td>RD_P77</td><td>Cohort 1</td><td>DEL-T</td><td>4, 7</td><td>NDD+</td></tr><tr><td>RD_P393</td><td>Cohort 2</td><td>DEL-INV-DEL</td><td>2</td><td>Epilepsy</td></tr><tr><td>RD_P405</td><td>Cohort 3</td><td>DUP-INS</td><td>3, 13</td><td>Growth retardation</td></tr><tr><td>RD_P406</td><td>Cohort 3</td><td>DUP-INS</td><td>4, 2</td><td>NDD, microcephaly</td></tr><tr><td>RD_P414</td><td>Cohort 3</td><td>Ring chromosome</td><td>18</td><td>NDD</td></tr></tbody></table><table-wrap-foot><p><italic>DEL</italic> deletion, <italic>NML</italic> normal, <italic>INV</italic> inversion, <italic>T</italic> translocation, <italic>INS</italic> insertion, <italic>NDD</italic> neurodevelopemental disorder, <italic>NDD+</italic> syndromic NDD</p></table-wrap-foot></table-wrap></p>
<p id="Par95"><italic>De novo</italic> CGRs, which may be seen as two or more <italic>de novo</italic> CNVs in the genome, can be observed in ~ 2% of patients with clinical indication to undergo array studies [<xref ref-type="bibr" rid="CR92">92</xref>] and are more common in some loci associated with genomic disorders. In <italic>MECP2</italic> duplication syndrome (MIM 300260) at Xq28 [<xref ref-type="bibr" rid="CR93">93</xref>, <xref ref-type="bibr" rid="CR94">94</xref>] and Pelizaeus-Merzbacher disease (MIM 312080) due to increased <italic>PLP1</italic> copy number at Xq22 [<xref ref-type="bibr" rid="CR94">94</xref>–<xref ref-type="bibr" rid="CR96">96</xref>], specific CGRs account for up to 30% of the pathological SVs. In autosomal <italic>loci</italic>, those CGRs represent a lower number of pathological SVs (&lt; 20%) [<xref ref-type="bibr" rid="CR97">97</xref>, <xref ref-type="bibr" rid="CR98">98</xref>], although technical ascertainment may explain lower detection. Even apparently “simple” non-recurrent rearrangements may actually consist of complex breakpoint junctions formed by multiple insertions of short templated segments (&lt; 100 nucleotides), which was shown in 27 to 35% of simple CNV junctions in disease-associated loci as well as polymorphic CNVs [<xref ref-type="bibr" rid="CR99">99</xref>]. Moreover, inversions, which cannot be detected by arrays, are associated with CGRs in 84 [<xref ref-type="bibr" rid="CR100">100</xref>] to 100% of the cases [<xref ref-type="bibr" rid="CR94">94</xref>, <xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR99">99</xref>].</p>
</sec>
<sec id="Sec28">
<title>Conclusions</title>
<p id="Par96">In conclusion, our data show that WGS robustly not only captures SNVs but also performs well for the detection of disease-causing CNVs and has the potential to detect STRs, ROH, and chromosomal rearrangements. These findings demonstrate that WGS may be used as a single test instead of performing two separate analyses to detect SVs and SNVs, such as CMA followed by WES, in addition to targeted analyses for specific repeat expansions and UPDs. Even though further studies are necessary to fully understand the limitations of WGS and how to interpret a normal result, for clinics already using clinical WGS for SNV analysis, the added value of mining the data for additional types of disease-causing mutations is high.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec29">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13073_2019_675_MOESM1_ESM.xlsx"><caption><p><bold>Additional file 1:</bold>
<bold>Table S1.</bold> Detailed information of individuals in Cohort 1.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13073_2019_675_MOESM2_ESM.pdf"><caption><p><bold>Additional file 2:</bold>
<bold>Figure S1.</bold> Flowchart showing different filtering steps of WGS SV analysis, <bold>Figure S2.</bold> Flowchart showing different filtering steps of WGS SNV analysis. <bold>Document S1.</bold> List of genes in the intellectual disability panel. <bold>Figure S3.</bold> Vcf2cytosure and array plots of illustrative cases. <bold>Figure S4.</bold> Breakpoint junction analysis of individuals RD_P77, RD_P393, RD_P400 and RD_P431. <bold>Document S2.</bold> Detailed clinical descriptions of individuals RD_P77, RD_P393, RD_P400 and RD_P431.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="13073_2019_675_MOESM3_ESM.xls"><caption><p><bold>Additional file 3:</bold>
<bold>Table S2.</bold> Number of detected CNVs using array and WGS.</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>WGS</term>
<def>
<p id="Par6">Whole-genome sequencing</p>
</def>
</def-item>
<def-item>
<term>SNV</term>
<def>
<p id="Par7">Single nucleotide variant</p>
</def>
</def-item>
<def-item>
<term>CNV</term>
<def>
<p id="Par8">Copy number variant</p>
</def>
</def-item>
<def-item>
<term>SV</term>
<def>
<p id="Par9">Structural variant</p>
</def>
</def-item>
<def-item>
<term>HPO</term>
<def>
<p id="Par10">Human Phenotype Ontology</p>
</def>
</def-item>
<def-item>
<term>STR</term>
<def>
<p id="Par11">Short tandem repeat</p>
</def>
</def-item>
<def-item>
<term>INDEL</term>
<def>
<p id="Par12">Small insertions and deletions</p>
</def>
</def-item>
<def-item>
<term>MPS</term>
<def>
<p id="Par13">Massively parallel sequencing</p>
</def>
</def-item>
<def-item>
<term>CMA</term>
<def>
<p id="Par14">Chromosomal microarray analysis</p>
</def>
</def-item>
<def-item>
<term>FISH</term>
<def>
<p id="Par15">Fluorescent in situ hybridization</p>
</def>
</def-item>
<def-item>
<term>WES</term>
<def>
<p id="Par16">Whole-exome sequencing</p>
</def>
</def-item>
<def-item>
<term>UPD</term>
<def>
<p id="Par17">Uniparental disomy</p>
</def>
</def-item>
<def-item>
<term>array-CGH</term>
<def>
<p id="Par18">Array comparative genomic hybridization</p>
</def>
</def-item>
<def-item>
<term>MLPA</term>
<def>
<p id="Par19">Multiplex ligation-dependent probe amplification</p>
</def>
</def-item>
<def-item>
<term>ACMG</term>
<def>
<p id="Par20">American College of Medical Genetics and Genomics</p>
</def>
</def-item>
<def-item>
<term>MAF</term>
<def>
<p id="Par21">Minor allele frequency</p>
</def>
</def-item>
<def-item>
<term>ExAC</term>
<def>
<p id="Par22">Exome Aggregation Consortium</p>
</def>
</def-item>
<def-item>
<term>RoH</term>
<def>
<p id="Par23">Run of homozygozity</p>
</def>
</def-item>
<def-item>
<term>NHEJ</term>
<def>
<p id="Par24">Non-homologous end-joining</p>
</def>
</def-item>
<def-item>
<term>VUS</term>
<def>
<p id="Par25">Variants of uncertain significance</p>
</def>
</def-item>
<def-item>
<term>CGR</term>
<def>
<p id="Par26">Complex genomic rearrangement</p>
</def>
</def-item>
<def-item>
<term>F</term>
<def>
<p id="Par27">Female</p>
</def>
</def-item>
<def-item>
<term>M</term>
<def>
<p id="Par28">Male</p>
</def>
</def-item>
<def-item>
<term>NDD</term>
<def>
<p id="Par29">Neurodevelopmental disorder</p>
</def>
</def-item>
<def-item>
<term>CTD</term>
<def>
<p id="Par30">Connective tissue disorder</p>
</def>
</def-item>
<def-item>
<term>SKD</term>
<def>
<p id="Par31">Skeletal dysplasia</p>
</def>
</def-item>
<def-item>
<term>NMD</term>
<def>
<p id="Par32">Neuromuscular disease</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisher’s Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>Johanna Lundin and Daniel Nilsson contributed equally to this work.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s13073-019-0675-1.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We are very grateful to the participating families. We would also like to thank UPPMAX for the use of computer infrastructure resources and the support from the National Genomics Infrastructure (NGI) Stockholm and Clinical Genomics Stockholm facility at the Science for Life Laboratory in providing assistance in massive parallel sequencing.</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>AL conceptualized the study, analyzed and interpreted data, and wrote the manuscript. JE and MP analyzed and interpreted data and contributed to the writing of the manuscript. JE, MåM, MaM, HS, and DN performed bioinformatics development. BMA, OB, CMBC, GG, PG, AH, PGH, EI, MJS, MK, KL, AgL, HM, MN, AnN, AmN, ES, ET, JW, SY, and AW provided patient samples, clinical information of patients, and/or analysis and interpretation of data. DN, JL, and VW conceptualized the study, analyzed and interpreted the data, and were major contributors in writing of the manuscript. All authors have read, edited, and approved the final manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>AL was supported by grants from the SciLifeLab national sequencing grant and the Stockholm County Council. AL and AN were supported by grants from the Swedish Research Council and the Swedish Brain Foundation. AN was supported by grants from The Hållsten Research Foundation. MP was supported by grants from Karolinska Institutet funding for doctoral education (KID) and The Royal Physiographic Society in Lund (Nilsson-Ehle donations). MaM was supported by the Knut and Alice Wallenberg Foundation as part of the National Bioinformatics Infrastructure Sweden at SciLifeLab.</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>The datasets supporting the conclusions of this article are included within the article and its additional files. All variants reported have been submitted to ClinVar [<xref ref-type="bibr" rid="CR62">62</xref>], accession number SCV000897707 (<italic>ATXN7</italic> expansion) and submission number SUB5433665. The consent provided by the research subjects did not permit sharing of the entire genome-wide data set. The in-house databases used in this article also contain information from clinical samples and are not publicly available due to compromise of patient confidentiality.</p>
<p>The following public databases and open source software were used:</p>
<p>Genome Reference Consortium Human Build 37 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.13/">https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.13/</ext-link>) [<xref ref-type="bibr" rid="CR36">36</xref>].</p>
<p>The Swedish variant frequency database (SweFreq) [<xref ref-type="bibr" rid="CR60">60</xref>] and the Swedish structural variant frequency database (SweFreq SVDB) [<xref ref-type="bibr" rid="CR49">49</xref>], both available from <ext-link ext-link-type="uri" xlink:href="https://swefreq.nbis.se/">https://swefreq.nbis.se/</ext-link> [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
<p>The Human Phenotype Ontology (HPO) term database (<ext-link ext-link-type="uri" xlink:href="http://compbio.charite.de/hpoweb/">http://compbio.charite.de/hpoweb/</ext-link>) [<xref ref-type="bibr" rid="CR55">55</xref>].</p>
<p>The Genomics England panel app (<ext-link ext-link-type="uri" xlink:href="https://panelapp.genomicsengland.co.uk/">https://panelapp.genomicsengland.co.uk/</ext-link>) [<xref ref-type="bibr" rid="CR52">52</xref>].</p>
<p>The ClinVar database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/">https://www.ncbi.nlm.nih.gov/clinvar/</ext-link>) [<xref ref-type="bibr" rid="CR62">62</xref>].</p>
<p>The Online Mendelian Inheritance in Man (OMIM; <ext-link ext-link-type="uri" xlink:href="https://www.omim.org">https://www.omim.org</ext-link>) [<xref ref-type="bibr" rid="CR40">40</xref>].</p>
<p>The University of California Santa Cruz (UCSC) Genome Browser (<ext-link ext-link-type="uri" xlink:href="http://www.genome.ucsc.edu">www.genome.ucsc.edu</ext-link>) [<xref ref-type="bibr" rid="CR65">65</xref>].</p>
<p>The Database of Genomic Variants (DGV; <ext-link ext-link-type="uri" xlink:href="http://dgv.tcag.ca">http://dgv.tcag.ca</ext-link>) [<xref ref-type="bibr" rid="CR38">38</xref>].</p>
<p>The Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources (DECIPHER; <ext-link ext-link-type="uri" xlink:href="http://decipher.sanger.ac.uk">http://decipher.sanger.ac.uk</ext-link>) [<xref ref-type="bibr" rid="CR39">39</xref>].</p>
<p>Exome Aggregation Consortium (ExAC v0.2; <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link>) [<xref ref-type="bibr" rid="CR59">59</xref>].</p>
<p>The Genome Aggregation Database (gnomAD; <ext-link ext-link-type="uri" xlink:href="https://gnomad.broadinstitute.org/">https://gnomad.broadinstitute.org/</ext-link>) [<xref ref-type="bibr" rid="CR70">70</xref>].</p>
<p>FindSV pipeline (<ext-link ext-link-type="uri" xlink:href="https://github.com/J35P312/FindSV">https://github.com/J35P312/FindSV</ext-link>) [<xref ref-type="bibr" rid="CR44">44</xref>].</p>
<p>SVDB (<ext-link ext-link-type="uri" xlink:href="https://github.com/J35P312/SVDB">https://github.com/J35P312/SVDB</ext-link>) [<xref ref-type="bibr" rid="CR47">47</xref>].</p>
<p>FreeBayes (<ext-link ext-link-type="uri" xlink:href="https://arxiv.org/abs/1207.3907">https://arxiv.org/abs/1207.3907</ext-link>) [<xref ref-type="bibr" rid="CR51">51</xref>].</p>
<p>vcf2cytosure (<ext-link ext-link-type="uri" xlink:href="https://github.com/NBISweden/vcf2cytosure">https://github.com/NBISweden/vcf2cytosure</ext-link>) [<xref ref-type="bibr" rid="CR56">56</xref>].</p>
<p>rhocall (<ext-link ext-link-type="uri" xlink:href="https://github.com/dnil/rhocall">https://github.com/dnil/rhocall</ext-link>) [<xref ref-type="bibr" rid="CR63">63</xref>].</p>
</notes>
<notes>
<title>Ethics approval and consent to participate</title>
<p id="Par97">The Regional Ethical Review Board in Stockholm, Sweden, approved the study (ethics permit numbers KS 2012/222-31/3 and 2012/2106-31/4). This ethics permit allows for use of clinical samples for analysis of scientific importance as part of clinical development. Included subjects were part of clinical cohorts investigated at our center. IRB approval for informed consent to participate in the study was waived; written informed consent was obtained for those participants for whom potentially identifiable clinical information was included in the manuscript. The research conformed to the principles of the Helsinki Declaration.</p>
</notes>
<notes>
<title>Consent for publication</title>
<p id="Par98">Written informed consent was obtained to publish clinical information.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par99">The authors declare that they have no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boycott</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Rath</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>JX</given-names>
</name>
<name>
<surname>Hartley</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Alkuraya</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Baynam</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>International cooperation to enable the diagnosis of all rare genetic diseases</article-title>
<source/>Am J Hum Genet
          <year>2017</year>
<volume>100</volume>
<issue>5</issue>
<fpage>695</fpage>
<lpage>705</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2017.04.003</pub-id>
<pub-id pub-id-type="pmid">28475856</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Genomes Project</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Abecasis</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Auton</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>DePristo</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>RM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An integrated map of genetic variation from 1,092 human genomes</article-title>
<source/>Nature.
          <year>2012</year>
<volume>491</volume>
<issue>7422</issue>
<fpage>56</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1038/nature11632</pub-id>
<pub-id pub-id-type="pmid">23128226</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mills</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Handsaker</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Alkan</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mapping copy number variation by population-scale genome sequencing</article-title>
<source/>Nature.
          <year>2011</year>
<volume>470</volume>
<issue>7332</issue>
<fpage>59</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1038/nature09708</pub-id>
<pub-id pub-id-type="pmid">21293372</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feuk</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Carson</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>Structural variation in the human genome</article-title>
<source/>Nat Rev Genet.
          <year>2006</year>
<volume>7</volume>
<issue>2</issue>
<fpage>85</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1038/nrg1767</pub-id>
<pub-id pub-id-type="pmid">16418744</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maretty</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sibbesen</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Villesen</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sequencing and de novo assembly of 150 genomes from Denmark as a population reference</article-title>
<source/>Nature.
          <year>2017</year>
<volume>548</volume>
<issue>7665</issue>
<fpage>87</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1038/nature23264</pub-id>
<pub-id pub-id-type="pmid">28746312</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ameur</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dahlberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Olason</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vezzi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Karlsson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SweGen: a whole-genome data resource of genetic variability in a cross-section of the Swedish population</article-title>
<source/>Eur J Hum Genet
          <year>2017</year>
<volume>25</volume>
<issue>11</issue>
<fpage>1253</fpage>
<lpage>1260</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2017.130</pub-id>
<pub-id pub-id-type="pmid">28832569</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Genomes Project</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Auton</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Garrison</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>HM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A global reference for human genetic variation</article-title>
<source/>Nature.
          <year>2015</year>
<volume>526</volume>
<issue>7571</issue>
<fpage>68</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1038/nature15393</pub-id>
<pub-id pub-id-type="pmid">26432245</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Karczewski</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Minikel</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Samocha</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fennell</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>
<source/>Nature.
          <year>2016</year>
<volume>536</volume>
<issue>7616</issue>
<fpage>285</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1038/nature19057</pub-id>
<pub-id pub-id-type="pmid">27535533</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Audano</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Sulovari</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Graves-Lindsay</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Cantsilieris</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sorensen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Welch</surname>
<given-names>AE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterizing the major structural variant alleles of the human genome</article-title>
<source/>Cell.
          <year>2019</year>
<volume>176</volume>
<issue>3</issue>
<fpage>663</fpage>
<lpage>675</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2018.12.019</pub-id>
<pub-id pub-id-type="pmid">30661756</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beaudet</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>The utility of chromosomal microarray analysis in developmental and behavioral pediatrics</article-title>
<source/>Child Dev
          <year>2013</year>
<volume>84</volume>
<issue>1</issue>
<fpage>121</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="doi">10.1111/cdev.12050</pub-id>
<pub-id pub-id-type="pmid">23311723</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Aradhya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Biesecker</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Brothman</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>NP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies</article-title>
<source/>Am J Hum Genet
          <year>2010</year>
<volume>86</volume>
<issue>5</issue>
<fpage>749</fpage>
<lpage>764</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.04.006</pub-id>
<pub-id pub-id-type="pmid">20466091</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waggoner</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wain</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Dubuc</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Conlin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hickey</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Lamb</surname>
<given-names>AN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)</article-title>
<source/>Genet Med
          <year>2018</year>
<volume>20</volume>
<issue>10</issue>
<fpage>1105</fpage>
<lpage>1113</lpage>
<pub-id pub-id-type="doi">10.1038/s41436-018-0040-6</pub-id>
<pub-id pub-id-type="pmid">29915380</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartman</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Beckman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Silverstein</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yohe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schomaker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Henzler</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Next generation sequencing for clinical diagnostics: five year experience of an academic laboratory</article-title>
<source/>Mol Genet Metab Rep
          <year>2019</year>
<volume>19</volume>
<fpage>100464</fpage>
<pub-id pub-id-type="doi">10.1016/j.ymgmr.2019.100464</pub-id>
<pub-id pub-id-type="pmid">30891420</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sudmant</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>A</given-names>
</name>
<name>
<surname>O'Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Malig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Copy number variation detection and genotyping from exome sequence data</article-title>
<source/>Genome Res
          <year>2012</year>
<volume>22</volume>
<issue>8</issue>
<fpage>1525</fpage>
<lpage>1532</lpage>
<pub-id pub-id-type="doi">10.1101/gr.138115.112</pub-id>
<pub-id pub-id-type="pmid">22585873</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Retterer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Juusola</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Vitazka</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Millan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gibellini</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical application of whole-exome sequencing across clinical indications</article-title>
<source/>Genet Med.
          <year>2016</year>
<volume>18</volume>
<issue>7</issue>
<fpage>696</fpage>
<lpage>704</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2015.148</pub-id>
<pub-id pub-id-type="pmid">26633542</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>El-Khechen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Farwell Hagman</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Powis</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Outcomes of diagnostic exome sequencing in patients with diagnosed or suspected autism spectrum disorders</article-title>
<source/>Pediatr Neurol
          <year>2017</year>
<volume>70</volume>
<fpage>34</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2017.01.033</pub-id>
<pub-id pub-id-type="pmid">28330790</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<mixed-citation publication-type="other">Srivastava S, Love-Nichols JA, Dies KA, Ledbetter DH, Martin CL, Chung WK, et al. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. Genet Med. 2019.</mixed-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dharmadhikari</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Al Masri</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Copy number variant and runs of homozygosity detection by microarrays enabled more precise molecular diagnoses in 11,020 clinical exome cases</article-title>
<source/>Genome Med
          <year>2019</year>
<volume>11</volume>
<issue>1</issue>
<fpage>30</fpage>
<pub-id pub-id-type="doi">10.1186/s13073-019-0639-5</pub-id>
<pub-id pub-id-type="pmid">31101064</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowling</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Amaral</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Finnila</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Hiatt</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Engel</surname>
<given-names>KL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genomic diagnosis for children with intellectual disability and/or developmental delay</article-title>
<source/>Genome Med.
          <year>2017</year>
<volume>9</volume>
<issue>1</issue>
<fpage>43</fpage>
<pub-id pub-id-type="doi">10.1186/s13073-017-0433-1</pub-id>
<pub-id pub-id-type="pmid">28554332</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Posey</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Luk</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Erikson</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mechanisms for the generation of two quadruplications associated with split-hand malformation</article-title>
<source/>Hum Mutat
          <year>2016</year>
<volume>37</volume>
<issue>2</issue>
<fpage>160</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="doi">10.1002/humu.22929</pub-id>
<pub-id pub-id-type="pmid">26549411</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eldomery</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Coban-Akdemir</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Harel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Gambin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Stray-Pedersen</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lessons learned from additional research analyses of unsolved clinical exome cases</article-title>
<source/>Genome Med.
          <year>2017</year>
<volume>9</volume>
<issue>1</issue>
<fpage>26</fpage>
<pub-id pub-id-type="doi">10.1186/s13073-017-0412-6</pub-id>
<pub-id pub-id-type="pmid">28327206</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jehee</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>VT</given-names>
</name>
<name>
<surname>Gurgel-Giannetti</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pietra</surname>
<given-names>RX</given-names>
</name>
<name>
<surname>Rubatino</surname>
<given-names>FVM</given-names>
</name>
<name>
<surname>Carobin</surname>
<given-names>NV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dual molecular diagnosis contributes to atypical Prader-Willi phenotype in monozygotic twins</article-title>
<source/>Am J Med Genet A
          <year>2017</year>
<volume>173</volume>
<issue>9</issue>
<fpage>2451</fpage>
<lpage>2455</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.38315</pub-id>
<pub-id pub-id-type="pmid">28631899</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karaca</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Posey</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Coban Akdemir</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Pehlivan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Harel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jhangiani</surname>
<given-names>SN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phenotypic expansion illuminates multilocus pathogenic variation</article-title>
<source/>Genet Med.
          <year>2018</year>
<volume>20</volume>
<issue>12</issue>
<fpage>1528</fpage>
<lpage>1537</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2018.33</pub-id>
<pub-id pub-id-type="pmid">29790871</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gross</surname>
<given-names>Andrew M.</given-names>
</name>
<name>
<surname>Ajay</surname>
<given-names>Subramanian S.</given-names>
</name>
<name>
<surname>Rajan</surname>
<given-names>Vani</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>Carolyn</given-names>
</name>
<name>
<surname>Bluske</surname>
<given-names>Krista</given-names>
</name>
<name>
<surname>Burns</surname>
<given-names>Nicole J.</given-names>
</name>
<name>
<surname>Chawla</surname>
<given-names>Aditi</given-names>
</name>
<name>
<surname>Coffey</surname>
<given-names>Alison J.</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>Alka</given-names>
</name>
<name>
<surname>Scocchia</surname>
<given-names>Alicia</given-names>
</name>
<name>
<surname>Thorpe</surname>
<given-names>Erin</given-names>
</name>
<name>
<surname>Dzidic</surname>
<given-names>Natasa</given-names>
</name>
<name>
<surname>Hovanes</surname>
<given-names>Karine</given-names>
</name>
<name>
<surname>Sahoo</surname>
<given-names>Trilochan</given-names>
</name>
<name>
<surname>Dolzhenko</surname>
<given-names>Egor</given-names>
</name>
<name>
<surname>Lajoie</surname>
<given-names>Bryan</given-names>
</name>
<name>
<surname>Khouzam</surname>
<given-names>Amirah</given-names>
</name>
<name>
<surname>Chowdhury</surname>
<given-names>Shimul</given-names>
</name>
<name>
<surname>Belmont</surname>
<given-names>John</given-names>
</name>
<name>
<surname>Roller</surname>
<given-names>Eric</given-names>
</name>
<name>
<surname>Ivakhno</surname>
<given-names>Sergii</given-names>
</name>
<name>
<surname>Tanner</surname>
<given-names>Stephen</given-names>
</name>
<name>
<surname>McEachern</surname>
<given-names>Julia</given-names>
</name>
<name>
<surname>Hambuch</surname>
<given-names>Tina</given-names>
</name>
<name>
<surname>Eberle</surname>
<given-names>Michael</given-names>
</name>
<name>
<surname>Hagelstrom</surname>
<given-names>R. Tanner</given-names>
</name>
<name>
<surname>Bentley</surname>
<given-names>David R.</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>Denise L.</given-names>
</name>
<name>
<surname>Taft</surname>
<given-names>Ryan J.</given-names>
</name>
</person-group>
<article-title>Copy-number variants in clinical genome sequencing: deployment and interpretation for rare and undiagnosed disease</article-title>
<source/>Genetics in Medicine
          <year>2018</year>
<volume>21</volume>
<issue>5</issue>
<fpage>1121</fpage>
<lpage>1130</lpage>
<pub-id pub-id-type="doi">10.1038/s41436-018-0295-y</pub-id>
<pub-id pub-id-type="pmid">30293986</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trost</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Thiruvahindrapuram</surname>
<given-names>B</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>WWL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A comprehensive workflow for read depth-based identification of copy-number variation from whole-genome sequence data</article-title>
<source/>Am J Hum Genet
          <year>2018</year>
<volume>102</volume>
<issue>1</issue>
<fpage>142</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2017.12.007</pub-id>
<pub-id pub-id-type="pmid">29304372</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellingford</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Barton</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bhaskar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>RL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Validation of copy number variation analysis for next-generation sequencing diagnostics</article-title>
<source/>Eur J Hum Genet
          <year>2017</year>
<volume>25</volume>
<issue>6</issue>
<fpage>719</fpage>
<lpage>724</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2017.42</pub-id>
<pub-id pub-id-type="pmid">28378820</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nilsson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pettersson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gustavsson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Forster</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hofmeister</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wincent</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Whole-genome sequencing of cytogenetically balanced chromosome translocations identifies potentially pathological gene disruptions and highlights the importance of microhomology in the mechanism of formation</article-title>
<source/>Hum Mutat
          <year>2017</year>
<volume>38</volume>
<issue>2</issue>
<fpage>180</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="doi">10.1002/humu.23146</pub-id>
<pub-id pub-id-type="pmid">27862604</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bramswig</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Ludecke</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Pettersson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bernier</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Cremer</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of new TRIP12 variants and detailed clinical evaluation of individuals with non-syndromic intellectual disability with or without autism</article-title>
<source/>Hum Genet
          <year>2017</year>
<volume>136</volume>
<issue>2</issue>
<fpage>179</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-016-1743-x</pub-id>
<pub-id pub-id-type="pmid">27848077</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grigelioniene</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nevalainen</surname>
<given-names>PI</given-names>
</name>
<name>
<surname>Reyes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thiele</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tafaj</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Molinaro</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A large inversion involving GNAS exon A/B and all exons encoding Gsalpha is associated with autosomal dominant pseudohypoparathyroidism type Ib (PHP1B)</article-title>
<source/>J Bone Miner Res
          <year>2017</year>
<volume>32</volume>
<issue>4</issue>
<fpage>776</fpage>
<lpage>783</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.3083</pub-id>
<pub-id pub-id-type="pmid">28084650</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dolzhenko</surname>
<given-names>E</given-names>
</name>
<name>
<surname>van Vugt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Bekritsky</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>van Blitterswijk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Narzisi</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Detection of long repeat expansions from PCR-free whole-genome sequence data</article-title>
<source/>Genome Res
          <year>2017</year>
<volume>27</volume>
<issue>11</issue>
<fpage>1895</fpage>
<lpage>1903</lpage>
<pub-id pub-id-type="doi">10.1101/gr.225672.117</pub-id>
<pub-id pub-id-type="pmid">28887402</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scocchia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wigby</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Masser-Frye</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Del Campo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Galarreta</surname>
<given-names>CI</given-names>
</name>
<name>
<surname>Thorpe</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical whole genome sequencing as a first-tier test at a resource-limited dysmorphology clinic in Mexico</article-title>
<source/>NPJ Genom Med.
          <year>2019</year>
<volume>4</volume>
<fpage>5</fpage>
<pub-id pub-id-type="doi">10.1038/s41525-018-0076-1</pub-id>
<pub-id pub-id-type="pmid">30792901</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilissen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hehir-Kwa</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Thung</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>van de Vorst</surname>
<given-names>M</given-names>
</name>
<name>
<surname>van Bon</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>MH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome sequencing identifies major causes of severe intellectual disability</article-title>
<source/>Nature.
          <year>2014</year>
<volume>511</volume>
<issue>7509</issue>
<fpage>344</fpage>
<lpage>347</lpage>
<pub-id pub-id-type="doi">10.1038/nature13394</pub-id>
<pub-id pub-id-type="pmid">24896178</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>Ellen</given-names>
</name>
<name>
<surname>Shakbatyan</surname>
<given-names>Rimma</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>Jason</given-names>
</name>
<name>
<surname>Rossetti</surname>
<given-names>Peter</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>Chet</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>Himanshu</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Chiao-Feng</given-names>
</name>
<name>
<surname>Lebo</surname>
<given-names>Matthew</given-names>
</name>
</person-group>
<article-title>Bioinformatics Workflow for Clinical Whole Genome Sequencing at Partners HealthCare Personalized Medicine</article-title>
<source/>Journal of Personalized Medicine
          <year>2016</year>
<volume>6</volume>
<issue>1</issue>
<fpage>12</fpage>
<pub-id pub-id-type="doi">10.3390/jpm6010012</pub-id>
<pub-id pub-id-type="pmid">4810391</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stranneheim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Engvall</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Naess</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lesko</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dahlberg</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rapid pulsed whole genome sequencing for comprehensive acute diagnostics of inborn errors of metabolism</article-title>
<source/>BMC Genomics
          <year>2014</year>
<volume>15</volume>
<fpage>1090</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2164-15-1090</pub-id>
<pub-id pub-id-type="pmid">25495354</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noll</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fiedler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cooley</surname>
<given-names>LD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical detection of deletion structural variants in whole-genome sequences</article-title>
<source/>NPJ Genom Med
          <year>2016</year>
<volume>1</volume>
<fpage>16026</fpage>
<pub-id pub-id-type="doi">10.1038/npjgenmed.2016.26</pub-id>
<pub-id pub-id-type="pmid">29263817</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<mixed-citation publication-type="other">Genome Reference Consortium Human Build 37. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.13/">https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.13/</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kearney</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Thorland</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Quintero-Rivera</surname>
<given-names>F</given-names>
</name>
<name>
<surname>South</surname>
<given-names>ST</given-names>
</name>
</person-group>
<article-title>Working Group of the American College of Medical Genetics Laboratory Quality Assurance C. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants</article-title>
<source/>Genet Med.
          <year>2011</year>
<volume>13</volume>
<issue>7</issue>
<fpage>680</fpage>
<lpage>685</lpage>
<pub-id pub-id-type="doi">10.1097/GIM.0b013e3182217a3a</pub-id>
<pub-id pub-id-type="pmid">21681106</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<mixed-citation publication-type="other">The Database of Genomic Variants. <ext-link ext-link-type="uri" xlink:href="http://dgv.tcag.ca">http://dgv.tcag.ca</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<mixed-citation publication-type="other">The Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources. <ext-link ext-link-type="uri" xlink:href="http://decipher.sanger.ac.uk">http://decipher.sanger.ac.uk</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<mixed-citation publication-type="other">The Online Mendelian Inheritance in Man. <ext-link ext-link-type="uri" xlink:href="https://www.omim.org">https://www.omim.org</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<mixed-citation publication-type="other">National Genomics Infrastructure (NGI), Stockholm, Sweden. <ext-link ext-link-type="uri" xlink:href="https://ngisweden.scilifelab.se/">https://ngisweden.scilifelab.se/</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<mixed-citation publication-type="other">Clinical Genomics, Stockholm, Sweden. <ext-link ext-link-type="uri" xlink:href="https://www.scilifelab.se/facilities/clinical-genomics-stockholm/">https://www.scilifelab.se/facilities/clinical-genomics-stockholm/</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DePristo</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Poplin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Garimella</surname>
<given-names>KV</given-names>
</name>
<name>
<surname>Maguire</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Hartl</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title>
<source/>Nat Genet
          <year>2011</year>
<volume>43</volume>
<issue>5</issue>
<fpage>491</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="doi">10.1038/ng.806</pub-id>
<pub-id pub-id-type="pmid">21478889</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<mixed-citation publication-type="other">The FindSV pipeline. <ext-link ext-link-type="uri" xlink:href="https://github.com/J35P312/FindSV">https://github.com/J35P312/FindSV</ext-link>. Accessed 17 Dec 2018.</mixed-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abyzov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Urban</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gerstein</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing</article-title>
<source/>Genome Res
          <year>2011</year>
<volume>21</volume>
<issue>6</issue>
<fpage>974</fpage>
<lpage>984</lpage>
<pub-id pub-id-type="doi">10.1101/gr.114876.110</pub-id>
<pub-id pub-id-type="pmid">21324876</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eisfeldt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vezzi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Olason</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nilsson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lindstrand</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>TIDDIT, an efficient and comprehensive structural variant caller for massive parallel sequencing data</article-title>
<source/>F1000Res
          <year>2017</year>
<volume>6</volume>
<fpage>664</fpage>
<pub-id pub-id-type="doi">10.12688/f1000research.11168.1</pub-id>
<pub-id pub-id-type="pmid">28781756</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<mixed-citation publication-type="other">SVDB. <ext-link ext-link-type="uri" xlink:href="https://github.com/J35P312/SVDB">https://github.com/J35P312/SVDB</ext-link>. Accessed 20 Sept 2018.</mixed-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLaren</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gil</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Riat</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Ritchie</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Thormann</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Ensembl variant effect predictor</article-title>
<source/>Genome Biol
          <year>2016</year>
<volume>17</volume>
<issue>1</issue>
<fpage>122</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-016-0974-4</pub-id>
<pub-id pub-id-type="pmid">27268795</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<mixed-citation publication-type="other">The Swedish structural variant frequency database. <ext-link ext-link-type="uri" xlink:href="https://swefreq.nbis.se/">https://swefreq.nbis.se/</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Handsaker</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wysoker</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fennell</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Homer</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The sequence alignment/map format and SAMtools</article-title>
<source/>Bioinformatics.
          <year>2009</year>
<volume>25</volume>
<issue>16</issue>
<fpage>2078</fpage>
<lpage>2079</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
<pub-id pub-id-type="pmid">19505943</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<mixed-citation publication-type="other">FreeBayes. <ext-link ext-link-type="uri" xlink:href="https://arxiv.org/abs/1207.3907">https://arxiv.org/abs/1207.3907</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<mixed-citation publication-type="other">Genomics England panel app. <ext-link ext-link-type="uri" xlink:href="https://panelapp.genomicsengland.co.uk/">https://panelapp.genomicsengland.co.uk/</ext-link>. Accessed 1 Jan 2018.</mixed-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Carmody</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vasilevsky</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>JOB</given-names>
</name>
<name>
<surname>Danis</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gourdine</surname>
<given-names>JP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources</article-title>
<source/>Nucleic Acids Res
          <year>2019</year>
<volume>47</volume>
<issue>D1</issue>
<fpage>D1018</fpage>
<lpage>D1D27</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gky1105</pub-id>
<pub-id pub-id-type="pmid">30476213</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Doelken</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Mungall</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Firth</surname>
<given-names>HV</given-names>
</name>
<name>
<surname>Bailleul-Forestier</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data</article-title>
<source/>Nucleic Acids Res
          <year>2014</year>
<volume>42</volume>
<issue>Database issue</issue>
<fpage>D966</fpage>
<lpage>D974</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkt1026</pub-id>
<pub-id pub-id-type="pmid">24217912</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<mixed-citation publication-type="other">Human Phenotype Ontology database. <ext-link ext-link-type="uri" xlink:href="http://compbio.charite.de/hpoweb/">http://compbio.charite.de/hpoweb/</ext-link>. Accessed 1 Jan 2018.</mixed-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<mixed-citation publication-type="other">vcf2cytosure. <ext-link ext-link-type="uri" xlink:href="https://github.com/NBISweden/vcf2cytosure">https://github.com/NBISweden/vcf2cytosure</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richards</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aziz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bale</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bick</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gastier-Foster</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>
<source/>Genet Med.
          <year>2015</year>
<volume>17</volume>
<issue>5</issue>
<fpage>405</fpage>
<lpage>424</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id>
<pub-id pub-id-type="pmid">25741868</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eisfeldt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pettersson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vezzi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wincent</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kaller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gruselius</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comprehensive structural variation genome map of individuals carrying complex chromosomal rearrangements</article-title>
<source/>PLoS Genet
          <year>2019</year>
<volume>15</volume>
<issue>2</issue>
<fpage>e1007858</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1007858</pub-id>
<pub-id pub-id-type="pmid">30735495</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<mixed-citation publication-type="other">Exome Aggregation Consortium (ExAC v0.2), <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<mixed-citation publication-type="other">The Swedish variant frequency database. <ext-link ext-link-type="uri" xlink:href="https://swefreq.nbis.se/">https://swefreq.nbis.se/</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<mixed-citation publication-type="other">Internal SNV scoring system. lhttps://<ext-link ext-link-type="uri" xlink:href="http://github.com/Clinical-Genomics/MIP/blob/master/templates/rank_model_cmms_-v1.25-.ini">github.com/Clinical-Genomics/MIP/blob/master/templates/rank_model_cmms_-v1.25-.ini</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<mixed-citation publication-type="other">The ClinVar database. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/">https://www.ncbi.nlm.nih.gov/clinvar/</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<mixed-citation publication-type="other">rhocall. <ext-link ext-link-type="uri" xlink:href="https://github.com/dnil/rhocall">https://github.com/dnil/rhocall</ext-link>. Accessed 1 Jan 2018.</mixed-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kent</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>BLAT--the BLAST-like alignment tool</article-title>
<source/>Genome Res
          <year>2002</year>
<volume>12</volume>
<issue>4</issue>
<fpage>656</fpage>
<lpage>664</lpage>
<pub-id pub-id-type="doi">10.1101/gr.229202</pub-id>
<pub-id pub-id-type="pmid">11932250</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<mixed-citation publication-type="other">The UCSC Genome Browser. <ext-link ext-link-type="uri" xlink:href="http://www.genome.ucsc.edu/">http://www.genome.ucsc.edu/</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sequeiros</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Seneca</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martindale</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias</article-title>
<source/>Eur J Hum Genet
          <year>2010</year>
<volume>18</volume>
<issue>11</issue>
<fpage>1188</fpage>
<lpage>1195</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2010.10</pub-id>
<pub-id pub-id-type="pmid">20179748</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eisfeldt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nilsson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Andersson-Assarsson</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Lindstrand</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>AMYCNE: confident copy number assessment using whole genome sequencing data</article-title>
<source/>PLoS One
          <year>2018</year>
<volume>13</volume>
<issue>3</issue>
<fpage>e0189710</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0189710</pub-id>
<pub-id pub-id-type="pmid">29579039</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nazaryan-Petersen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Eisfeldt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pettersson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lundin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nilsson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wincent</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Replicative and non-replicative mechanisms in the formation of clustered CNVs are indicated by whole genome characterization</article-title>
<source/>PLoS Genet
          <year>2018</year>
<volume>14</volume>
<issue>11</issue>
<fpage>e1007780</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1007780</pub-id>
<pub-id pub-id-type="pmid">30419018</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Ernst</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hanscom</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Heilbut</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Blumenthal</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration</article-title>
<source/>Nat Genet
          <year>2012</year>
<volume>44</volume>
<issue>4</issue>
<fpage>390</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2202</pub-id>
<pub-id pub-id-type="pmid">22388000</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<mixed-citation publication-type="other">The Genome Aggregation Database (gnomAD). <ext-link ext-link-type="uri" xlink:href="https://gnomad.broadinstitute.org/">https://gnomad.broadinstitute.org/</ext-link>. Accessed 21 Oct 2019.</mixed-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Helbling-Leclerc</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Topaloglu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cruaud</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tesson</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Weissenbach</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy</article-title>
<source/>Nat Genet
          <year>1995</year>
<volume>11</volume>
<issue>2</issue>
<fpage>216</fpage>
<lpage>218</lpage>
<pub-id pub-id-type="doi">10.1038/ng1095-216</pub-id>
<pub-id pub-id-type="pmid">7550355</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hisado-Oliva</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ruzafa-Martin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sentchordi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Funari</surname>
<given-names>MFA</given-names>
</name>
<name>
<surname>Bezanilla-Lopez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Alonso-Bernaldez</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature</article-title>
<source/>Genet Med.
          <year>2018</year>
<volume>20</volume>
<issue>1</issue>
<fpage>91</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2017.66</pub-id>
<pub-id pub-id-type="pmid">28661490</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krejci</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Masri</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fontaine</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mekikian</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Weis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Prats</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis</article-title>
<source/>J Cell Sci
          <year>2005</year>
<volume>118</volume>
<issue>Pt 21</issue>
<fpage>5089</fpage>
<lpage>5100</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.02618</pub-id>
<pub-id pub-id-type="pmid">16234329</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartnik</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chun-Hui Tsai</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Stankiewicz</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Disruption of the SCN2A and SCN3A genes in a patient with mental retardation, neurobehavioral and psychiatric abnormalities, and a history of infantile seizures</article-title>
<source/>Clin Genet
          <year>2011</year>
<volume>80</volume>
<issue>2</issue>
<fpage>191</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2010.01526.x</pub-id>
<pub-id pub-id-type="pmid">20807223</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fry</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Rees</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mantripragada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Blake</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pathogenic copy number variants and SCN1A mutations in patients with intellectual disability and childhood-onset epilepsy</article-title>
<source/>BMC Med Genet
          <year>2016</year>
<volume>17</volume>
<issue>1</issue>
<fpage>34</fpage>
<pub-id pub-id-type="doi">10.1186/s12881-016-0294-2</pub-id>
<pub-id pub-id-type="pmid">27113213</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harkin</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Iona</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Dibbens</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pelekanos</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Zuberi</surname>
<given-names>SM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The spectrum of SCN1A-related infantile epileptic encephalopathies</article-title>
<source/>Brain.
          <year>2007</year>
<volume>130</volume>
<issue>Pt 3</issue>
<fpage>843</fpage>
<lpage>852</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awm002</pub-id>
<pub-id pub-id-type="pmid">17347258</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanoye</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Gurnett</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Holland</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>George</surname>
<given-names>AL</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Kearney</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Novel SCN3A variants associated with focal epilepsy in children</article-title>
<source/>Neurobiol Dis
          <year>2014</year>
<volume>62</volume>
<fpage>313</fpage>
<lpage>322</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2013.10.015</pub-id>
<pub-id pub-id-type="pmid">24157691</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pettersson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vaz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hammarsjo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Eisfeldt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>CMB</given-names>
</name>
<name>
<surname>Hofmeister</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alu-Alu mediated intragenic duplications in IFT81 and MATN3 are associated with skeletal dysplasias</article-title>
<source/>Hum Mutat
          <year>2018</year>
<volume>39</volume>
<issue>10</issue>
<fpage>1456</fpage>
<lpage>1467</lpage>
<pub-id pub-id-type="doi">10.1002/humu.23605</pub-id>
<pub-id pub-id-type="pmid">30080953</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Szafranski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Akdemir</surname>
<given-names>ZC</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Magrina</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mechanisms for complex chromosomal insertions</article-title>
<source/>PLoS Genet
          <year>2016</year>
<volume>12</volume>
<issue>11</issue>
<fpage>e1006446</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1006446</pub-id>
<pub-id pub-id-type="pmid">27880765</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clark</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Stark</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Farnaes</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>White</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Dimmock</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases</article-title>
<source/>NPJ Genom Med.
          <year>2018</year>
<volume>3</volume>
<fpage>16</fpage>
<pub-id pub-id-type="doi">10.1038/s41525-018-0053-8</pub-id>
<pub-id pub-id-type="pmid">30002876</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Schulz-Trieglaff</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schlesinger</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kallberg</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications</article-title>
<source/>Bioinformatics.
          <year>2016</year>
<volume>32</volume>
<issue>8</issue>
<fpage>1220</fpage>
<lpage>1222</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btv710</pub-id>
<pub-id pub-id-type="pmid">26647377</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rausch</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zichner</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Schlattl</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stutz</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Benes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Korbel</surname>
<given-names>JO</given-names>
</name>
</person-group>
<article-title>DELLY: structural variant discovery by integrated paired-end and split-read analysis</article-title>
<source/>Bioinformatics.
          <year>2012</year>
<volume>28</volume>
<issue>18</issue>
<fpage>i333</fpage>
<lpage>i3i9</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/bts378</pub-id>
<pub-id pub-id-type="pmid">22962449</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>FermiKit: assembly-based variant calling for Illumina resequencing data</article-title>
<source/>Bioinformatics.
          <year>2015</year>
<volume>31</volume>
<issue>22</issue>
<fpage>3694</fpage>
<lpage>3696</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btv412</pub-id>
<pub-id pub-id-type="pmid">26220959</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Layer</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Quinlan</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>IM</given-names>
</name>
</person-group>
<article-title>LUMPY: a probabilistic framework for structural variant discovery</article-title>
<source/>Genome Biol
          <year>2014</year>
<volume>15</volume>
<issue>6</issue>
<fpage>R84</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2014-15-6-r84</pub-id>
<pub-id pub-id-type="pmid">24970577</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kosugi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Momozawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Terao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kubo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kamatani</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Comprehensive evaluation of structural variation detection algorithms for whole genome sequencing</article-title>
<source/>Genome Biol
          <year>2019</year>
<volume>20</volume>
<issue>1</issue>
<fpage>117</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-019-1720-5</pub-id>
<pub-id pub-id-type="pmid">31159850</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eberle</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Fritzilas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Krusche</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kallberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Bekritsky</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A reference data set of 5.4 million phased human variants validated by genetic inheritance from sequencing a three-generation 17-member pedigree</article-title>
<source/>Genome Res
          <year>2017</year>
<volume>27</volume>
<issue>1</issue>
<fpage>157</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="doi">10.1101/gr.210500.116</pub-id>
<pub-id pub-id-type="pmid">27903644</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tammimies</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kaur</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Thiruvahindrapuram</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder</article-title>
<source/>JAMA.
          <year>2015</year>
<volume>314</volume>
<issue>9</issue>
<fpage>895</fpage>
<lpage>903</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2015.10078</pub-id>
<pub-id pub-id-type="pmid">26325558</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anazi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maddirevula</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Faqeih</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Alsedairy</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Alzahrani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Shamseldin</surname>
<given-names>HE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield</article-title>
<source/>Mol Psychiatry
          <year>2017</year>
<volume>22</volume>
<issue>4</issue>
<fpage>615</fpage>
<lpage>624</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2016.113</pub-id>
<pub-id pub-id-type="pmid">27431290</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindstrand</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Frangakis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>McFadden</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Willer</surname>
<given-names>JR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Copy-number variation contributes to the mutational load of Bardet-Biedl syndrome</article-title>
<source/>Am J Hum Genet
          <year>2016</year>
<volume>99</volume>
<issue>2</issue>
<fpage>318</fpage>
<lpage>336</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2015.04.023</pub-id>
<pub-id pub-id-type="pmid">27486776</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lieden</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kvarnung</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nilssson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sahlin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lundberg</surname>
<given-names>ES</given-names>
</name>
</person-group>
<article-title>Intragenic duplication--a novel causative mechanism for SATB2-associated syndrome</article-title>
<source/>Am J Med Genet A
          <year>2014</year>
<volume>164A</volume>
<issue>12</issue>
<fpage>3083</fpage>
<lpage>3087</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36769</pub-id>
<pub-id pub-id-type="pmid">25251319</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders</article-title>
<source/>Cell.
          <year>2007</year>
<volume>131</volume>
<issue>7</issue>
<fpage>1235</fpage>
<lpage>1247</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2007.11.037</pub-id>
<pub-id pub-id-type="pmid">18160035</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>CMB</given-names>
</name>
<name>
<surname>Wuster</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An organismal CNV Mutator phenotype restricted to early human development</article-title>
<source/>Cell.
          <year>2017</year>
<volume>168</volume>
<issue>5</issue>
<fpage>830</fpage>
<lpage>842</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2017.01.037</pub-id>
<pub-id pub-id-type="pmid">28235197</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalho</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Pehlivan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ramocki</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Alleva</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>LM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Replicative mechanisms for CNV formation are error prone</article-title>
<source/>Nat Genet
          <year>2013</year>
<volume>45</volume>
<issue>11</issue>
<fpage>1319</fpage>
<lpage>1326</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2768</pub-id>
<pub-id pub-id-type="pmid">24056715</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalho</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Ramocki</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Pehlivan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Gonzaga-Jauregui</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inverted genomic segments and complex triplication rearrangements are mediated by inverted repeats in the human genome</article-title>
<source/>Nat Genet
          <year>2011</year>
<volume>43</volume>
<issue>11</issue>
<fpage>1074</fpage>
<lpage>1081</lpage>
<pub-id pub-id-type="doi">10.1038/ng.944</pub-id>
<pub-id pub-id-type="pmid">21964572</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beck</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Banser</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gambin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Stubbolo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Complex genomic rearrangements at the PLP1 locus include triplication and quadruplication</article-title>
<source/>PLoS Genet
          <year>2015</year>
<volume>11</volume>
<issue>3</issue>
<fpage>e1005050</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1005050</pub-id>
<pub-id pub-id-type="pmid">25749076</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalho</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Bartnik</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pehlivan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Evidence for disease penetrance relating to CNV size: Pelizaeus-Merzbacher disease and manifesting carriers with a familial 11 Mb duplication at Xq22</article-title>
<source/>Clin Genet
          <year>2012</year>
<volume>81</volume>
<issue>6</issue>
<fpage>532</fpage>
<lpage>541</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2011.01716.x</pub-id>
<pub-id pub-id-type="pmid">21623770</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Nagamani</surname>
<given-names>SC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alu-mediated diverse and complex pathogenic copy-number variants within human chromosome 17 at p13.3</article-title>
<source/>Hum Mol Genet
          <year>2015</year>
<volume>24</volume>
<issue>14</issue>
<fpage>4061</fpage>
<lpage>4077</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddv146</pub-id>
<pub-id pub-id-type="pmid">25908615</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Harel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Burglen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chantot-Bastaraud</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nonrecurrent 17p11.2p12 rearrangement events that result in two concomitant genomic disorders: the PMP22-RAI1 contiguous gene duplication syndrome</article-title>
<source/>Am J Hum Genet
          <year>2015</year>
<volume>97</volume>
<issue>5</issue>
<fpage>691</fpage>
<lpage>707</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2015.10.003</pub-id>
<pub-id pub-id-type="pmid">26544804</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalho</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Mechanisms underlying structural variant formation in genomic disorders</article-title>
<source/>Nat Rev Genet
          <year>2016</year>
<volume>17</volume>
<issue>4</issue>
<fpage>224</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="doi">10.1038/nrg.2015.25</pub-id>
<pub-id pub-id-type="pmid">26924765</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collins</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Brand</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Redin</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Hanscom</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Antolik</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>MR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Defining the diverse spectrum of inversions, complex structural variation, and chromothripsis in the morbid human genome</article-title>
<source/>Genome Biol
          <year>2017</year>
<volume>18</volume>
<issue>1</issue>
<fpage>36</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-017-1158-6</pub-id>
<pub-id pub-id-type="pmid">28260531</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>